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A B S T R A C T
Background
Leishmaniasis is caused by the Leishmania parasite, and transmitted by infected phlebotomine sandflies. Of the two distinct clinical
syndromes, cutaneous leishmaniasis (CL) affects the skin and mucous membranes, and visceral leishmaniasis (VL) affects internal
organs. Approaches to prevent transmission include vector control by reducing human contact with infected sandflies, and reservoir
control, by reducing the number of infected animals.
Objectives
To assess the effects of vector and reservoir control interventions for cutaneous and for visceral leishmaniasis.
Search methods
We searched the following databases to 13 January 2015: Cochrane Infectious Diseases Group Specialized Register, CENTRAL,
MEDLINE, EMBASE, LILACS and WHOLIS, Web of Science, and RePORTER. We also searched trials registers for ongoing trials.
Selection criteria
Randomized controlled trials (RCTs) evaluating the effects of vector and reservoir control interventions in leishmaniasis-endemic
regions.
Data collection and analysis
Two review authors independently searched for trials and extracted data from included RCTs. We resolved any disagreements by
discussion with a third review author. We assessed the quality of the evidence using the GRADE approach.
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Main results
We included 14 RCTs that evaluated a range of interventions across different settings. The study methods were generally poorly
described, and consequently all included trials were judged to be at high or unclear risk of selection and reporting bias. Only seven
trials reported clinical outcome data which limits our ability to make broad generalizations to different epidemiological settings and
cultures.
Cutaneous leishmaniasis
One four-arm RCT from Afghanistan compared indoor residual spraying (IRS), insecticide-treated bednets (ITNs), and insecticide-
treated bedsheets, with no intervention. Over 15 months follow-up, all three insecticide-based interventions had a lower incidence of
CL than the control area (IRS: risk ratio (RR) 0.61, 95% confidence interval (CI) 0.38 to 0.97, 2892 participants, moderate quality
evidence; ITNs: RR 0.32, 95% CI 0.18 to 0.56, 2954 participants, low quality evidence; ITS: RR 0.34, 95% CI 0.20 to 0.57, 2784
participants, low quality evidence). No difference was detected between the three interventions (low quality evidence). One additional
trial of ITNs from Iran was underpowered to show a difference.
Insecticide treated curtains were compared with no intervention in one RCT from Venezuela, where there were no CL episodes in
the intervention areas over 12 months follow-up compared to 142 in control areas (RR 0.00, 95% CI 0.00 to 0.49, one trial, 2938
participants, low quality evidence).
Personal protection using insecticide treated clothing was evaluated by two RCTs in soldiers, but the trials were underpowered to
reliably detect effects on the incidence of CL (RR 0.40, 95% CI 0.13 to 1.20, two trials, 558 participants, low quality evidence).
Visceral leishmaniasis
In a single RCT of ITNs versus no intervention from India and Nepal, the incidence of VL was low in both groups and no difference
was detected (RR 0.99, 95% CI 0.46 to 2.15, one trial, 19,810 participants, moderate quality evidence).
Two trials from Brazil evaluated the effects of culling infected dogs compared to no intervention or IRS. Although they report a
reduction in seroconversion over 18 months follow-up, they did not measure or report effects on clinical disease.
Authors’ conclusions
Using insecticides to reduce phlebotomine sandfly numbers may be effective at reducing the incidence of CL, but there is insufficient
evidence from trials to know whether it is better to spray the internal walls of houses or to treat bednets, curtains, bedsheets or clothing.
P L A I N L A N G U A G E S U M M A R Y
Vector and reservoir control for preventing leishmaniasis
This review summarises trials evaluating different measures to prevent leishmaniasis. After searching for relevant trials up to January
2015, we included 14 randomized controlled trials.
What is vector and reservoir control and how might they prevent leishmaniasis?
Leishmaniasis is a group of infectious diseases caused by Leishmania parasites, which are transmitted between humans and animals by
the bite of infected phlebotomine sandflies. There are two main clinical diseases: cutaneous leishmaniasis (CL), where parasites infect
the skin, and visceral leishmaniasis (VL), where they infect the internal organs.
Leishmaniasis could be prevented by reducing human contact with infected phlebotomine sandflies (the vector), or by reducing the
number of infected animals (the reservoir).
What the research says?
Cutaneous leishmaniasis
Using insecticides to reduce the number of sandflies may be effective at reducing the number of new cases of cutaneous leishmaniasis
(low quality evidence). However, there is not enough evidence to know whether it is better to use insecticides to spray the internal walls
of houses, or use insecticide treated bednets, bedsheets, or curtains.
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Personal protection using insecticide treated clothing was also evaluated in two small trials in soldiers, but the trials were too small to
know whether this was effective (low quality evidence).
Visceral leishmaniasis
Insecticide treated nets may not be effective at preventing visceral leishmaniasis but this has only been tested in a single trial from India
and Nepal (low quality evidence).
Although culling dogs is sometimes discussed as a potential way to reduce visceral leishmaniasis, this has not been tested in trials
measuring clinical disease.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Indoor residual spraying (IRS) versus no intervention for preventing leishmaniasis
Patient or population: People at risk of cutaneous leishmaniasis (CL) or visceral leishmaniasis (VL)
Settings: CL or VL endemic areas
Intervention: IRS
Comparison: No intervent ion
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(trials)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
No intervention IRS
Vector density - - Not pooled (4 trials) ⊕⊕⊕©
moderate1,2,3
Reduct ions in sandf ly
abundance were seen
af ter IRS spraying in all
f our trials
CL cases
> 12 months follow-up
52 per 1000 32 per 1000
(20 to 50)
RR 0.61
(0.38 to 0.97)
2892
(1 trial)
⊕⊕⊕©
moderate1,4,5,6
-
VL cases
> 2 years follow-up
- - - (0 trials) - -
* The basis for the assumed risk (for example, the median control group risk across trials) is provided in footnotes. The corresponding risk (and its 95% CI) is based on the
assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: conf idence interval; RR: risk rat io; CL: cutaneous leishmaniasis; VL: visceral leishmaniasis; IRS: indoor residual spraying.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1Downgraded by 1 for serious risk of bias: Trials are at high or unclear risk of select ion bias and report ing bias.
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2No serious inconsistency: Reduct ions in sandf ly abundance were seen af ter IRS spraying in all f our trials (compared to
control areas).
3No serious indirectness: The trials used insect icides shown to be ef fect ive in the trial area. Trials were f rom India, Bangladesh,
Nepal, Venezuela and Brazil.
4The assumed risk of CL over 12 months follow-up is taken f rom the control group in Reyburn 2000 AFG. This trial was
conducted in Afghanistan f rom 1997 to 1998.
5No serious indirectness: This single trial was conducted in urban areas of Afghanistan using lambdacyhalothrin at a target
rate of 30 mg/ m². Further trials f rom dif ferent sett ings would increase conf idence in this result .
6Downgraded by 1 for serious imprecision: The 95%CI is wide and includes clinically important ef fects and no real dif f erence.
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B A C K G R O U N D
Description of the condition
Leishmaniasis is a group of diseases caused by infection with Leish-
mania species parasites. Two broad clinical syndromes affect peo-
ple (Reithinger 2007):
1. Cutaneous or tegumental leishmaniasis (CL), where
Leishmania parasites infect the skin or mucous membranes; and
2. Visceral leishmaniasis (VL), also known as Kala-Azar, where
Leishmania parasites infect internal organs, such as the spleen,
liver, bone marrow and lymph nodes.
The World Health Organization (WHO) considers leishmaniasis
to be one of the most serious parasitic diseases in terms of preva-
lence and geographical distribution. Approximately 350 million,
often impoverished, people are at risk of contracting leishmaniasis
(Alvar 2006). Worldwide, more than 20 Leishmania species are
known to infect humans across 98 countries or territories (Alvar
2012). The WHO estimates that one million to 1.3 million new
cases occur each year; one million for CL and 300,000 for VL
(WHO 2009).
In the Old World (North Africa, the Mediterranean, the Mid-
dle East, Northeast of India, and Central Asia), CL is most com-
monly caused by Leishmania major, Leishmania tropica and Leish-
mania aethiopica, and less frequently by Leishmania infantum and
Leishmania donovani (Alvar 2012). In the New World (Central
and South America), CL may be caused by the Leishmania mexi-
cana species complex (particularly L. mexicana, Leishmania ama-
zonensis and Leishmania venezuelensis) or the Leishmania Viannia
sub-genus (particularlyLeishmania (V) braziliensis,Leishmania (V)
panamensis,Leishmania (V) guyanensis and Leishmania (V) peru-
viana). Half of the skin lesions caused by L. mexicana heal in three
months, while those due to L. (V) braziliensis,L. (V) panamen-
sis and L. (V) guyanensis persist for much longer and may evolve
to mucocutaneous leishmaniasis. VL is caused by L. donovani in
the Indian subcontinent and East Africa, and L. infantum in the
Middle East, the Mediterranean basin and South America (WHO
2010).
Several drug (topical and systemic), physical and immunological
therapeutic modalities have been used for leishmaniasis treatment
(Das 2008; González 2008; González 2009; Romero 2010).
The infection is transmitted between humans (anthroponotic
leishmaniasis) or from animals to humans (zoonotic leishmania-
sis) by the bite of infected phlebotomine sandflies (Desjeux 1996).
Sandflies can breed in cracks, in walls or among rocks, animals’
burrows, caves, damp leaf litter in forests, holes in the ground, sta-
ble floors, poultry houses and termite hills. Both male and female
phlebotomine sandflies feed on sugar and plants juices but the fe-
males also blood-feed. Female phlebotomine sandflies usually bite
at night; some species feed indoors (endophagic), whilst others
feed outdoors (exophagic) (Roberts 2006). In the OldWorld, the
sandfly vectors belong to the genus Phlebotomus, while in the New
World they belong to the genus Lutzomyia.Due to a co-evolution
process, there is an association between the Leishmania species,
its animal reservoir (host) and the phlebotomine sandfly species
involved in the transmission of leishmaniasis (Table 1).
Description of the intervention
Leishmaniasis could be prevented by reducing the number of in-
fected phlebotomine sandflies (vector control), or by reducing the
animal reservoir of Leishmania in areas where the disease in com-
monly zoonotic (reservoir control). One further possibility is the
development of effective human vaccines, but these are evaluated
in a separate Cochrane Review (Khanjani 2009).
In general, phlebotomine sandflies are highly sensitive to insecti-
cides although some resistance to DDT has been reported (Dinesh
2010). Insecticidemay be sprayed onto the internal walls of houses,
also known as indoor residual spraying (IRS), or impregnated into
bednets (also known as insecticide treated nets (ITNs)), curtains
(insecticide treated curtains (ITCs)), bedsheets (insecticide treated
sheets (ITS)) or clothing. IRS is the most widely used intervention
for controlling endophagic phlebotomine sandflies but needs to
be repeated regularly, which decreases its long-term sustainability
(Davies 2003). ITNs and ITCs also need to be replaced or retreated
regularly but usually less frequently than IRS, and therefore may
be more sustainable. However, most phlebotomine sandfly activ-
ity occurs around sunset, generally before people have retired for
the night, which may limit their effects (Roberts 2006). In areas
where phlebotomine sandflies are typically exophagic or leishma-
niasis represents an occupational hazard, such as for soldiers or
hunters, the use of insect repellents or protective clothes may be
the only preventive measures available (Alexander 2003), but it is
unlikely to be practical or affordable for poor populations living
in highly endemic areas.
Alternatively, phlebotomine sandfly numbers could be reduced by
removing breeding sites from the environment through activities
such as re-plastering of cracks in walls with mud or lime (Kishore
2006).
The methods used to control the reservoir (host) of zoonotic leish-
maniasis depend on which animals act as reservoirs. Dogs play an
important role as leishmaniasis reservoirs in some areas, and devel-
opment of appropriate control measures is necessary (Courtenay
2009; Dogan 2006; Quinell 2009). Other animal reservoirs, such
as rodents, have been targeted through poisonous baits (Roberts
2006).
Since disease control efforts are focused on reducing sandfly-hu-
man contact or sandfly populations, other leishmaniasis control
strategies on socioeconomic aspects should include (Alvar 2006):
• Fight against poverty.
• Gender equality and elimination of other sociocultural
barriers.
• Access to health care (mainly in the case of human
reservoirs like anthroponotic VL or post kala-azar dermal
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leishmaniasis (PKDL), and asymptomatic infections, including
direct non-medical cost as transport).
• House construction and placement of domestic animal
enclosures (poor housing conditions are associated with
ecological factors that increase the risk of human-vector contact).
• Educational health programmes and community
participation.
Why it is important to do this review
A wide range of leishmaniasis preventive options have been used
in different parts of the world. This Cochrane Review aims to
summarise available research categorised by disease forms, settings
and geographical regions.
O B J E C T I V E S
To assess the effects of vector and reservoir control interventions
on all forms of leishmaniasis.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomized controlled trials (RCTs).
Types of participants
People living in leishmaniasis endemic regions.
Types of interventions
Any intervention that aims to reduce leishmaniasis incidence
through vector or reservoir control.
Types of outcome measures
Primary outcomes
People developing CL or VL infections.
Secondary outcomes
1. Estimates of the vector density measured by an appropriate
technique (adult sandfly density estimated by counts of vectors
either landing on exposed body parts of humans acting as baits
or collected resting inside buildings, for example, on walls).
2. Number of participants with positive immunological or
biochemical tests that detect contact with the parasite (for
example, leishmanin skin test conversion rates or lymphocyte
proliferation rates, or both).
3. Adverse effects on people.
4. Adherence to control measures; for example, the extent to
which specified intervention components were delivered as
prescribed.
5. Measures of environmental impact (assessment of the
possible impact - positive or negative - that the interventions
may have on the natural environment) or sustainability
(assessment of the ability to change biological and human
processes, functions, biodiversity and productivity), or both.
Search methods for identification of studies
We attempted to identify all relevant trials regardless of language or
publication status (published, unpublished, in press and ongoing).
Electronic searches
We searched the following databases up to 13 January 2015:
Cochrane Infectious Diseases Group (CIDG) Specialized Regis-
ter, Appendix 1); the Cochrane Central Register of Controlled
Trials (CENTRAL) from the Cochrane Library, Issue 12, 2014
(Appendix 2); MEDLINE (PubMed.gov from 1900, Appendix
3); EMBASE (Data Star, from 1947, Appendix 4); LILACS, from
1982 (Appendix 5),WHOLIS (Appendix 6),Web of Science (Sci-
ence Direct, from 1900, Appendix 7); and RePORTExpenditures
and Results (RePORTER) which contains information on con-
trolled trials being funded or supported by the US Department
of Health and Human Services http://projectreporter.nih.gov/re-
porter.cfm, Appendix 8).
Ongoing trials databases
We searched the following ongoing trials registers on 13 January
2015 using the strategies in Appendix 9:
• MetaRegister of Controlled trials on www.controlled-
trials.com;
• US National Institutes of Health Register on
www.clinicaltrials.gov;
• Ongoing Skin Trials Register on www.nottingham.ac.uk/
ongoingskintrials;
• Australian and New Zealand Clinical Trials Registry on
www.anzctr.org.au;
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• World Health Organization (WHO) International Clinical
Trials Registry Platform (ICTRP) on www.who.int/trialsearch.
Searching other resources
References from published studies
We looked at the bibliographies of all papers identified by these
strategies.
Researchers, organizations and pharmaceutical companies
We contacted researchers in the field to identify additional studies
eligible for inclusion.
Adverse events search
We searched for adverse or side effects of interventions using the
search strategy in Appendix 10.
Data collection and analysis
Selection of studies
At least two review authors (AF, MP or UG) independently
screened the title and abstract of all identified citations for poten-
tial eligibility using an eligibility form. We resolved any disagree-
ments by discussion between the review authors, with referral to
a third review author if necessary (UG or JA). We removed dupli-
cate publications.
Data extraction and management
At least two review authors (CE and AF; CE and MP; or all
three) independently performed data extraction using a pre-de-
signed data extraction form. We resolved any disagreements by
discussion or referral to another review author (UG).
We extracted information regarding the trial characteristics and
trial methods, including setting, comparability between sites and
outcomes and how these were measured. For dichotomous out-
comes, we extracted the number of participants experiencing the
event and the number of participants for each treatment group.
For continuous outcomes, we extracted the arithmetic mean and
standard deviation (SD) for each treatment group, together with
the number of participants in each group. However, if the data
were reported using geometric means we recorded this informa-
tion and extracted a SD on the log scale. If median values were
used, we extracted medians and ranges. For data on an interval
scale, we extracted the number of treatment events and control
group and the total person time at risk in each group or the rate
ratio and a measure of variance (for example, standard error).
We extracted the number of randomized participants and analysed
them in each treatment group and the denominator populations
for estimating incidence for each trial and outcome. We checked
for co-interventions and we examined whether both control and
intervention arms experienced the same co-interventions.
For cluster-RCTs, we extracted information on the number of
clusters, average size of the cluster, unit of randomization (such as
communities or villages), adjustment for clustering or other co-
variates in the statistical analysis, and estimates of the intra-cluster
correlation coefficient (ICC) for each outcome.Where results were
adjusted for clustering, we extracted the point estimate with 95%
confidence intervals (CIs); otherwise we adjusted the unadjusted
results before incorporating them into our analyses.
Assessment of risk of bias in included studies
Pairs of review authors (includingAF,MPorCE) (AF,MP andCE)
independently assessed the risk of bias for each included trial using
a ’Risk of bias’ assessment form. We resolved any discrepancies
between the results of the risk of bias analysis by referral to a third
review author (UG). We assigned judgments concerning the risk
of bias for each component classified as ’high’, ’low’ or ’unclear’
risk of bias, respectively. We recorded the information in a ’Risk
of bias’ table and ’Risk of bias’ graph.
Measures of treatment effect
For dichotomous outcomes, we presented all results as risk ra-
tios (RR) with 95% CIs. Where trial authors presented results as
cluster-adjusted odds ratio we converted this to a RR using the
guidance in the Cochrane Handbook for Systematic Reviews of In-
terventions (Higgins 2009).We presented vector density and other
outcomes, such as ages of cases, descriptively in tables.
Unit of analysis issues
Where cluster-RCTs met the inclusion criteria, we assessed
whether the trial authors had taken account of clustering in the
primary analysis. If trial authors had appropriately adjusted for
clustering we extracted the adjusted data for inclusion in our anal-
ysis. Where trial authors had not adjusted for clustering, we per-
formed an approximate adjustment using estimates of the ICC
derived from similar studies (Table 2).
Dealing with missing data
We reported whether participants or communities were lost to
follow-up during the time period of the trial. We analysed data
according to a complete case analysis. We performed sensitivity
analyses to asses the effect of missing data and to ensure the ro-
bustness of our conclusions.
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Assessment of heterogeneity
When we combined trials in a meta-analysis, we examined forest
plots to detect overlapping CIs, and applied the Chi² test (using
a P value of 0.10 to indicate statistical heterogeneity), and the
I² statistic (using a value of 50% to denote moderate levels of
heterogeneity).
Assessment of reporting biases
We searched for citation and multiple publication bias, language
bias and outcome reporting bias.
Data synthesis
Three review authors (DS, TE and UG) analysed the data using
RevMan 2014 and presented all results with 95% CIs.
In individually RCTs and cluster-RCTs, we calculated RRs and
95% CIs for dichotomous data. We did not analyse vector densi-
ties, but merely presented the results of the individual trials. We
could not consider meta-analysis to calculate a weighted effect
across trials regarding participants (different Leishmania spp infec-
tions), interventions (reservoir and vector control) and outcome.
We aimed to perform an intention-to-treat (ITT) analysis when
the trial authors accounted for all randomized participants; oth-
erwise we performed a complete-case analysis.
When we detected no statistically significant heterogeneity, we
applied a fixed-effect model. When we observed statistically sig-
nificant heterogeneity within groups that could not be explained
by subgroup or sensitivity analyses, we applied a random-effects
model to synthesize the data. However, when substantial hetero-
geneity was determined, we did not carry out meta-analysis but
presented a forest plot with the pooled effect suppressed and re-
ported the I² statistic and P value from a Chi² test.
We described qualitatively the main adverse effects related with
insecticides.
Subgroup analysis and investigation of heterogeneity
Weanticipated that effectswould varywith leishmania species, and
the geographic setting of the trial, and grouped studies accordingly.
Sensitivity analysis
We planned to conduct sensitivity analysis examining effects of
bias risk but there were too few included trials to do this.
Assessment of quality of evidence
We assessed the quality of evidence using the GRADE approach
(GRADEWorking Group 2004) and GRADEpro 2015 software.
R E S U L T S
Description of studies
See: Characteristics of included studies and Characteristics of
excluded studies.
Results of the search
We identified 32 trials from our searches, of which we included 14
and excluded 18. We found one ongoing RCT (Characteristics of
ongoing studies).We have detailed our search results in a PRISMA
flow diagram (Figure 1).
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Figure 1. Study flow diagram.
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Included studies
We have provided details of the 14 included trials in the
Characteristics of included studies tables.
Trial design
Ten trials were cluster-RCTs that randomized villages (Rojas 2006
COL), urban sectors (Costa 2007 BRA; Emami 2009 IRN;
Kroeger 2002 VEN; Werneck 2014 BRA), hamlets or households
(Chowdhury 2011 BGD; Joshi 2009 ASIA; Picado 2010a ASIA;
Reyburn 2000 AFG) or individual houses (Kelly 1997 BRA). Two
were paired RCTs that randomized houses (Dinesh 2008 IND;
Feliciangeli 2003 VEN). Two were individually RCTs in soldiers
(Asilian 2003a IRN; Soto 1995 COL).
Participants
Seven trials were conducted in Asia: Afghanistan (Reyburn 2000
AFG), Iran (Asilian 2003a IRN;Emami2009 IRN), India (Dinesh
2008 IND), Bangladesh (Chowdhury 2011 BGD), India and
Nepal (Picado 2010a ASIA), India, Bangladesh and Nepal (Joshi
2009 ASIA). Seven trials were conducted in South America:
Colombia (Rojas 2006 COL; Soto 1995 COL), Brazil (Costa
2007 BRA; Kelly 1997 BRA; Werneck 2014 BRA) and Venezuela
(Feliciangeli 2003 VEN; Kroeger 2002 VEN).
Settings
Most trials mentioned the which Leishmania species were endemic
in the area and therefore assumed this species was the causative
agent of leishmaniasis. One RCT reported that CL was caused
by L. tropica (Emami 2009 IRN), three RCTS by L. chagasi (L.
infantum) (Costa 2007 BRA; Kelly 1997 BRA; Werneck 2014
BRA), one trial by L. braziliensis and L. panamensis (Rojas 2006
COL), and one trial by L. braziliensis and L. mexicana (Feliciangeli
2003 VEN).Three RCTs reported that VL was caused by L. dono-
vani (Chowdhury 2011 BGD; Dinesh 2008 IND; Picado 2010a
ASIA). Four RCTs failed to mention theLeishmania species in-
volved: one in a VL area (Joshi 2009 ASIA) and three in CL areas
(Asilian 2003a IRN; Kroeger 2002 VEN; Soto 1995 COL). One
RCT reported that infections in the respective endemic areas were
caused by anthroponotic CL (Reyburn 2000 AFG).
Interventions
We found 12 RCTs that evaluated the use of insecticides in vec-
tor control. Trials used a variety of different interventions, includ-
ing IRS (five trials: Chowdhury 2011 BGD; Feliciangeli 2003
VEN; Joshi 2009 ASIA; Kelly 1997 BRA; Reyburn 2000 AFG),
ITNs (six trials: Chowdhury 2011 BGD; Emami 2009 IRN; Joshi
2009 ASIA; Picado 2010a ASIA; Reyburn 2000 AFG; Rojas 2006
COL), ITCs (one trial: Kroeger 2002 VEN), ITS (two trials: Kelly
1997 BRA; Reyburn 2000 AFG) or insecticide treated uniforms
(two trials: Asilian 2003a IRN; Soto 1995 COL).
Two additional trials evaluated IRS plus reservoir control through
spraying houses and animal pens and eliminating infected dogs
(Costa 2007 BRA; Werneck 2014 BRA).
Outcomes
Seven trials reported clinical outcomes as the incidence of new
CL cases (Asilian 2003a IRN; Emami 2009 IRN; Kroeger 2002
VEN; Reyburn 2000 AFG; Rojas 2006 COL; Soto 1995 COL),
or VL (Picado 2010a ASIA). Four trials used immunological or
biochemical tests (Costa 2007 BRA; Picado 2010a ASIA; Rojas
2006 COL;Werneck 2014 BRA) for detecting the presence of the
Leishmania parasite on participants (for example, leishmanin skin
test conversion rates or lymphocyte proliferation rates, or both).
Six trials (Costa 2007 BRA; Dinesh 2008 IND; Emami 2009
IRN; Joshi 2009 ASIA; Kelly 1997 BRA; Kroeger 2002 VEN)
reported on entomological outcomes (vector density). Only three
trials reported adverse effects (Asilian 2003a IRN; Rojas 2006
COL; Soto 1995 COL). Two trials reported acceptability and
adherence to control measures from participants (for example, the
extent to which specified intervention components were delivered
as prescribed) (Picado 2010a ASIA; Reyburn 2000 AFG).
Excluded studies
We excluded 18 RCTs and listed the reasons in the Characteristics
of excluded studies table.
Risk of bias in included studies
We have described the risk of bias of each included trial in the
Characteristics of included studies tables. We included a ’Risk of
bias’ summary (Figure 2) and a ’Risk of bias’ graph (Figure 3).
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Figure 2. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included trials.
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Figure 3. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included trial.
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Allocation
AIl included trials stated or implied that allocation was random-
ized; however only five trials described the method of sequence
generation (Emami 2009 IRN; Kroeger 2002 VEN; Picado 2010a
ASIA; Rojas 2006 COL; Werneck 2014 BRA), and no trials de-
scribed allocation concealment.
Blinding
Two included RCTs were double-blinded (Asilian 2003a IRN;
Soto 1995 COL), two were single-blinded (Kroeger 2002 VEN;
Reyburn 2000 AFG), and ten trials did not use any blinding or
did not mention it.
Incomplete outcome data
An individually RCT accounted for losses to follow-up (Asilian
2003a IRN), and the other individually RCT reported no drop-
outs (Soto 1995 COL). However, Asilian 2003a IRN only assessed
participants who completed the use of the preventive measure.We
took all participants that were randomized at the beginning of the
trial to evaluate the final effect of the intervention. We assumed
that missing data were failures. The trial did not specify if they
were post randomization or later losses. Overall there was no losses
of clusters or the losses were not reported.
Selective reporting
One of the included trials, Dinesh 2008 IND, reported only the
results that showed statistically significant differences between in-
tervention groups, instead of all results.
Other potential sources of bias
In nine of the included RCTs the trial authors did not provide a
conflict of interest declaration and in five of the included RCTs
trial authors declared no competing interests. See risk of bias tables
in Characteristics of included studies for more details.
Effects of interventions
See: Summary of findings for the main comparison Summary
of findings table 1; Summary of findings 2 Summary of findings
table 2; Summary of findings 3 Summary of findings table 3;
Summary of findings 4 Summary of findings table 4; Summary
of findings 5 Summary of findings table 5; Summary of findings
6 Summary of findings table 6; Summary of findings 7 Summary
of findings table 7
Section A: Intervention versus no intervention
IRS versus no intervention
(See Summary of findings for the main comparison)
Effect on vector density
Four cluster-RCTs evaluated the effect of IRS on vector density
(Table 3). The insecticide used was deltamethrin (20 mg/m²)
in Bangladesh (Chowdhury 2011 BGD), DDT (5%) in India,
and alpha-cypermethrine (0.025 mg/m²) in Nepal (Joshi 2009
ASIA), all against the vector Phlebotomous argentipes; and lambda-
cyhalothrin (25mg/m²) in Brazil (Kelly 1997 BRA) andVenezuela
(Feliciangeli 2003 VEN), with main vectors: Lu. longipalpis and
Lu. ovallesi, respectively. The longest follow-up was 12 months.
All four trials reported substantial reductions in vectors at the inter-
vention sites, although the variation in measurement and report-
ing of these outcomes precludes meta-analysis. Despite marked
seasonal variation in the abundance of flies, large reductions were
seen with IRS compared to control areas in the two trials fromAsia
in areas of VL which randomized clusters of houses (Chowdhury
2011 BGD; Joshi 2009 ASIA). This effect lasted for nine months
in Bangladesh but was no longer present at 12 months, and was
only measured at a single time-point of five months in India,
Bangladesh and Nepal. The two trials from South America in ar-
eas of CL which randomized individual houses or chicken sheds
reported short term reductions after the intervention but did not
provide data to allow us to quantify the magnitude or duration of
this effect (Feliciangeli 2003 VEN; Kelly 1997 BRA).
Effect on disease
CL: One cluster-RCT from Afghanistan evaluated the effect of
IRS on CL incidence (Reyburn 2000 AFG). IRS was applied once
using lambdacyhalothrin (30 mg/m²). The cumulative analysis of
new cases over 15 months showed a marked reduction in clinical
cases with IRS (Intervention 36/1133 (3.2%); control 92/1759
(5.2 %); RR 0.61, 95% CI 0.38 to 0.97, one trial, 2892 partici-
pants in approximately 600 clusters, Analysis 1.1). The effect ap-
pears to be consistent across age groups (Table 4).
VL:No trials evaluated the effects of IRS on VL incidence. How-
ever, one trial assessed the effect on seroconversion in aVLendemic
area in Brazil (Werneck 2014 BRA) and found no statistically sig-
nificant difference in seroconversion over 18 months post inter-
vention (Intervention 47/93 (50.5%); control 60/95 (63.2%); RR
0.86, 95% CI 0.63 to 1.17, one trial, 295 participants in 40 clus-
ters, Analysis 1.2).
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ITNs versus no intervention or untreated nets
(See Summary of findings 2)
Effect on vector density
Three cluster-RCTs evaluated the effect of ITNs on vector density
(Table 5). Two trials in areas of VL from Asia used PermaNet®
bednets impregnated with deltamethrin (55 mg/m²) (Chowdhury
2011 BGD; Joshi 2009 ASIA, vector: P. argentipes); and one trial
in Iran used Olyset® bednets impregnated with permethrin (2%)
(Emami 2009 IRN), main vector: P. sergenti). All three trials ran-
domized clusters of houses (hamlets, neighbourhoods or city sec-
tors).
In Bangladesh, there was a substantial reduction in vector density
in the ITN areas for 12 months post intervention (Chowdhury
2011 BGD). In the multicentre trial from Asia, Joshi 2009 ASIA,
the overall difference between intervention and control sites was
not statistically significant. However the trial authors reported that
it was significant at the India and Bangladesh sites but not in
Nepal. In Iran, the trial authors reported a statistically significant
reduction but did not provide data to enable quantification of the
magnitude or duration of effect (Emami 2009 IRN). Variation in
measurement and reporting of these outcomes precluded meta-
analysis.
One additional cluster-RCT in India that randomized clusters of
houses compared two different types of ITNs (PermaNet® bed-
nets impregnated with 55 mg/m² deltamethrin and Olyset® bed-
nets impregnated with 2% permethrin) with two control groups
of untreated nets (Table 6). The trial authors reported a statisti-
cally significant reduction in male P. argentipes in areas with ITNs
compared to untreated nets, but no difference in female P. argen-
tipes or other vectors (Dinesh 2008 IND).
Effect on disease
CL: Two cluster-RCTs from Afghanistan and Iran evaluated the
effect of ITNson the incidence ofCL (Emami 2009 IRN;Reyburn
2000 AFG). In Afghanistan, ITNs impregnated with permethrin
(0.5 g/m²) were distributed to all households, and the cumulative
analysis of new cases over 15 months showed a marked reduction
in CL in areas with ITNs compared to control areas (Intervention
20/1195 (1.7%); control 92/1759 (5.2%); RR 0.32, 95%CI 0.18
to 0.56, one trial, 2954 participants in approximately 600 clusters,
Analysis 2.1). In Iran, there again appeared to be a large reduction
inCLcases.However, the trial authors did not adjust for the cluster
design. Our approximate adjustment for clustering in this trial
using the ICC from Rojas 2006 COL suggests this difference may
not reach standard levels of statistical significance (intervention
2/3810 (0.05%); control 117/3815 (3.1%); RR 0.02, 95% CI
0.00 to 1.48, one trial, 7625 participants in 12 clusters, Analysis
2.1). In the combined analysis of both trials there was a significant
reduction of CL cases.
VL: One cluster-RCT evaluated the effect of PermaNet® ITNs
impregnated with deltamethrin (55 mg/m²) on VL in India and
Nepal (Picado 2010a ASIA). The overall risk of VL during the 30
months follow-upwas 37/9829 (0.38%) in the intervention group
and 40/9981 (0.40%) in the control group (RR 0.99, 95% CI
0.46 to 2.15, one trial, 19,810 participants in 26 clusters, Analysis
2.2). In the same trial, there was also no significant difference
in the risk of seroconversion (determined by direct agglutination
test) in those who had negative results (titre < 1:1600) at baseline
(RR 0.90, 95% CI 0.49 to 1.65, one trial, 19,810 participants,
Analysis 2.3).
ITCs versus untreated curtains or no curtains
(See Summary of findings 3)
Effect on vector density
One cluster-RCT evaluated the effect of ITCs on vector density
(Kroeger 2002 VEN; Table 7). This trial randomized city sectors
from urban Venezuela (main vectors: L. youngi and L. ovallesi) and
compared ITCs of lambdacyhalothrin (12.5 mg/m²) with unim-
pregnated curtains or no curtains. There were no significant dif-
ferences in mean number of phlebotomine sandflies per house
per night between the intervention and control groups before the
placement of the curtains (averaged over 150 consecutive nights,
January to June 2000; P = 0.706), but the mean was substantially
lower in the intervention houses three months after the interven-
tion (P < 0.001).
Effect on disease
CL: In Kroeger 2002 VEN, over 12 months follow-up, the inci-
dence of clinical cases of CL was 0/1351 (0%) in the interven-
tion group and 142/1587 (9%) in the control group. The trial au-
thors reported a cluster adjusted mean difference in CL incidence
between the intervention and control areas which is statistically
significant (MD 8.3, 95% CI 5.0 to 11.7; authors’ own figures).
For comparison with other interventions we calculated an approx-
imate RR by using a value of 0.5 events in the intervention group
and adjusted for clustering using the ICC from Rojas 2006 COL
(RR 0.00, 95% CI 0.00 to 0.49, one trial, 2938 participants in
14 clusters, Analysis 3.1).
VL: No trials evaluated the effects of ITCs on VL incidence.
ITS versus no intervention
(Summary of findings 4)
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Effect on vector density
One cluster-RCT in areas of Brazil with VL evaluated the effects of
treating sheets with lambdacyhalothrin (20 mg/m²) and hanging
them near the chicken shed (Kelly 1997 BRA; Table 8). This
trial, with main vector Lu. longipalpis, randomized chicken sheds
but did not provide data to allow us to quantify the magnitude
or duration of this effect. The trial authors reported short term
reductions in geometric mean phlebotomine sandflies per trap
after the intervention,which only differed statistically fromcontrol
sheds at week 12 post-intervention.
Effect on disease
CL: Reyburn 2000 AFG, a cluster-RCT from Afghanistan, eval-
uated the effect of treating bedsheets with permethrin (1 g/m²)
on CL incidence. In the cumulative analysis of new cases over 15
months follow-up there were substantially fewer in the interven-
tion households (Intervention 18/1025 (1.8%); control 92/1759
(5.2 %); RR 0.34, 95% CI 0.20 to 0.57, one trial, 2784 partici-
pants in approximately 600 clusters, Analysis 4.1). The effect ap-
pears to be consistent across age groups (Table 4).
VL: No studies.
Insecticide treated uniforms versus no intervention
(See Summary of findings 5)
Effect on disease
CL: Two individually randomized trials evaluated the effect of
impregnating soldiers uniforms with permethrin on the incidence
of CL (Asilian 2003a IRN; Soto 1995 COL). The trials were
small and underpowered to confidently detect or exclude effects.
The combined meta-analysis did not find a statistically significant
effect (two trials, 558 participants, Analysis 5.1). However, in Soto
1995 COL the incidence in the control group was 18/143 over 12
weeks (12%), and just 4/143 (3%) in soldiers with impregnated
uniforms which did reach standard levels of statistical significance
(RR 0.22, 95%CI 0.08 to 0.64). Asilian 2003a IRN reported that
no side effects occurred, while Soto 1995 COL reported that two
out of 229 soldiers with impregnated uniforms had skin irritation
and pruritus that required treatment.
VL: No trials evaluated the effects of insecticide treated uniforms
on VL incidence.
Reservoir control versus no intervention
Effect on disease
VL: No trials evaluated the effect of reservoir control on clinical
disease but one trial from an area endemic with VL in Brazil (
Werneck 2014 BRA) found a 38% reduction in seroconversion
over 18 months post-elimination of infected dogs (RR 0.62, 95%
CI 0.42 to 0.91, one trial, 376 participants in 20 clusters, Analysis
6.1).
Environmental modification (EVM) versus no intervention
Effect on vector density
VL: The two cluster-RCTs in areas of Asia with VL evaluated the
effect of EVM on vector density (Table 9). Both trials that ran-
domized clusters of houses used trained community mobilizers to
promote the filing of cracks in walls and floors with mud or lime
(Chowdhury 2011 BGD; Joshi 2009 ASIA). Neither trial found
evidence of statistically significant reductions in phlebotomine
sandflies compared to no intervention up to 12 months follow-
up. Although the variation in measurement and reporting of these
outcomes precludes meta-analysis.
Effect on disease
No trials evaluated the effect of EVM on disease.
Multifaceted intervention versus no intervention
(See Summary of findings 6)
Effect on disease
CL: Rojas 2006 COL, a cluster-RCT from Colombia, evaluated
a multifaceted intervention combining ITNs (deltamethrin), per-
sonal insect repellent (diethyltoluamide 20%), painting of tree
trunks around residences with whitewash, and health education.
Over one year follow-up there was no statistically significant differ-
ence in new cases of CL between intervention and control villages
(Intervention 10/1791 (0.6%); control 23/1840 (1.3%); RR 0.45,
95% CI 0.13 to 1.50, one trial, 3631 participants in 20 clusters,
Analysis 7.1), and also no difference in seroconversion (Interven-
tion 82/1066 (7.7%); control 80/1034 (7.7%); RR 0.99, 95% CI
0.51 to 1.95, one trial, 2100 participants in 20 clusters, Analysis
7.2). The trial authors reported adverse events in 2% of those in
the intervention groups. The most common adverse effects were
headache and itching.
VL: One additional trial from an area endemic with VL in Brazil
(Werneck 2014 BRA) evaluated IRS plus culling of infected dogs
and found no statistically significant difference in seroconversion
over 18 months post intervention (Intervention 37/144 (2.6%);
control 42/113 (3.7%); RR 0.75, 95% CI 0.51 to 1.11, one trial,
336 participants in 40 clusters, Analysis 7.2).
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Section B: Comparisons of different interventions
IRS versus ITNs, ITCs or ITS
(See Summary of findings 7)
Effect on vector density
Two cluster-RCTs in areas of Asia with VL evaluated the compar-
ative effect of IRS and ITNs (55 mg/m² deltamethrin) on vector
density (Table 10). In a trial from Bangladesh, India and Nepal,
Joshi 2009 ASIA, the pooled data with a follow-up at five months
on trapped phlebotomine sandflies (P. argentipes) in houses showed
that IRS was effective with an average sandfly reduction of about
50%, but the ITNs had very little effect. In the other trial from
Bangladesh, Chowdhury 2011 BGD, both interventions were as-
sociated with an overall decrease in total sandfly (P. argentipes) den-
sity at five months. The variation in measurement and reporting
of these outcomes precludes meta-analysis.
Kelly 1997 BRA, a cluster-RCT in areas of Brazil with VL, in-
cluded a comparison of IRS with insecticide-impregnated (20 mg/
m² lambdacyhalothrin) cotton sheets or blankets (focal coverage)
(Table 11). Following IRS intervention, Lu.longipalpis abundance
fell by only 45% versus 90% after ITS intervention on week 12
post-intervention.
Effect on disease
CL: In the multi-arm cluster-RCT from Afghanistan, Reyburn
2000 AFG, the differences in CL incidence between clusters allo-
cated to IRS, ITNs or ITS did not reach standard levels of statis-
tical significant differences among interventions over 15 months
(IRS versus ITNs, RR 1.9, 95% CI 0.98 to 3,69 Analysis 8.1; IRS
versus ITS, RR 1.83 95% CI 0.92 to 3.64 Analysis 9.1; and ITNs
versus ITS, RR 0.96 95% CI 0.45 to 2.08 Analysis 10.1; one trial,
3353 participants in approximately 600 clusters).
VL: No trials evaluated the effect of this comparison on VL inci-
dence.
IRS versus EVM
Effect on vector density
Two cluster-RCTs in areas of Asia with VL also evaluated the
effect of IRS versus EVM on vector density (Chowdhury 2011
BGD; Joshi 2009 ASIA; Table 12). The pooled data in both trials
showed that EVM had no or very little effect on total sandfly (P.
argentipes) density at fivemonths but the variation inmeasurement
and reporting of these outcomes precludes meta-analysis.
Effect on disease
No trials evaluated the effect of this comparison on leishmaniasis.
ITNs vs EVM
Effect on vector density
Twocluster-RCTs in areas of AsiawithVLalso compared long-last-
ing ITN with EVM (Chowdhury 2011 BGD; Joshi 2009 ASIA;
Table 13). Only ITNs had an important effect on the average re-
duction of phlebotomine sandflies (P. argentipes) at five months.
The variation in measurement and reporting of these outcomes
precludes meta-analysis.
Effect on disease
No trials evaluated the effect of this comparison on leishmaniasis.
Reservoir control versus IRS
Effect on disease
VL: Costa 2007 BRA, a cluster-RCT based in a VL-endemic area
in Brazil (367 inhabitants; 213 seronegatives), evaluated the ef-
fects of insecticide spraying of animal pens, and reservoir control
(eliminating infected dogs) on seroconversion, using IRS of houses
alone as the control group. Trial authors did not present the total
number of participants in each of the four intervention groups.
IRS of houses and elimination of infected dogs appeared to reduce
seroconversion compared to IRS alone (RR 0.20, 95% CI 0.05
to 0.85, one trial, number of participants not available, Analysis
11.1). However, this effect was not seen in a similar comparison
of IRS of houses and animal pens plus elimination of infected
dogs versus IRS alone (RR 0.69, 95% CI 0.27 to 1.76, one trial,
number of participants not available, Analysis 11.1).
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
ITNs versus no intervention for preventing leishmaniasis
Patient or population: People at risk of CL or VL
Settings: CL or VL endemic areas
Intervention: ITNs
Comparison: No intervent ion
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95%CI)
No of participants
(trials)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
No intervention ITNs
Vector density - - Not pooled (3 trials) ⊕⊕©©
low1,2,3,4
Two trials found a re-
duct ion in vector num-
bers post-intervent ion
and one did not
CL cases
> 12 months follow-up
52 per 1000 16 per 1000
(9 to 28)
RR 0.31
(0.18 to 0.53)
10,579
(2 trials)
⊕⊕©©
low2,5,6,7,11
-
VL cases
> 2 years follow-up
4 per 1000 4 per 1000
(2 to 9)
RR 0.99
(0.46 to 2.15)
19,810
(1 trial)
⊕⊕⊕©
moderate8,9,10
-
* The basis for the assumed risk is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed risk in the comparison group and the relative
effect of the intervent ion (and its 95% CI).
CI: conf idence interval; RR: risk rat io; CL: cutaneous leishmaniasis; VL: visceral leishmaniasis; ITN: insect icide treated bednet.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
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1Three RCTs evaluated vector density, but one did not present before and af ter data and only stated the dif ference was
stat ist ically signif icant.
2Downgraded by 1 for serious risk of bias: Trials are at high or unclear risk of select ion bias and report ing bias.
3Downgraded by 1 for serious inconsistency: Chowdhury 2011 BGD reports a stat ist ically signif icant dif f erence in total vector
numbers over 12 months follow-up, Emami 2009 IRN reports stat ist ically signif icant reduct ion but did not provide data. Joshi
2009 ASIA found no dif ference in mean number of vectors per household.
4No serious indirectness: Chowdhury 2011 BGD distributed PermaNet® 2.0 to all households in trial sites in Bangladesh,
Emami 2009 IRN distributed Olyset® in Iran, and Joshi 2009 distributed PermaNet® to households in India, Bangladesh and
Nepal.
5The assumed risk of CL over 12 months follow-up is taken f rom Reyburn 2000 AFG which contributed 99.5%of weight to this
analysis. This trial was conducted in Afghanistan f rom 1997 to 1998.
6No serious indirectness: These two trials were conducted in urban areas of Iran (Olyset® nets), and Afghanistan (family size
bednets impregnated with 0.5 g/ m² of permethrin). The f indings would be expected to apply to other endemic areas.
7No serious inconsistency: The two trials found sim ilar ef fects. However, once adjusted for clustering the result was not
stat ist ically signif icant in the trial f rom Iran.
8The assumed risk of VL over 2 years months follow-up is taken f rom the control group of Picado 2010a ASIA - a study
conducted in India and Nepal in 2006/ 09.
9No serious indirectness: This single trial was conducted in two areas (India and Nepal) using PermaNet® 2.0.
10Downgraded by 1 for serious imprecision: This trial f ound no dif ference between ITNs and control areas. However the 95%
CI remains wide and includes the possibility of clinically important ef fects.
11Downgraded by 1 for serious indirectness: There are single trials f rom part icular geographical areas.
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ITCs versus no intervention for preventing leishmaniasis
Patient or population: People at risk of CL or VL
Settings: CL or VL endemic areas
Intervention: ITCs
Comparison: No intervent ion
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(trials)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
No intervention Insecticide treated
curtains
Vector density - - - -
(1 trial)
⊕⊕©©
low1,2,3
Vector density was sub-
stant ially lower at 12
months post-interven-
t ion
CL cases
> 12 months follow-up
52 per 1000 0 per 1000
(0 to 25)
RR 0.00
(0.00 to 0.49)
2938
(1 trial)
⊕⊕©©
low1,2,4,5
-
VL cases
> 2 years follow-up
- - - (0 trials) - -
* The basis for the assumed risk is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed risk in the comparison group and the relative
effect of the intervent ion (and its 95% CI).
CI: conf idence interval; RR: risk rat io; CL: cutaneous leishmaniasis; VL: visceral leishmaniasis;ITC: insect icide treated curtains.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1Downgraded by 1 for serious risk of bias: Trials were at high or unclear risk of select ion bias and report ing bias.2
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2Downgraded by 1 for serious indirectness: There are single trials f rom part icular geographical areas. The result may not
be applicable elsewhere. Polyester curtains were impregnated with 12.5 mg/ m2 lambdacyhalothrin at baseline and af ter 6
months.
3No serious imprecision: At 12 months post intervent ion vector density was substant ially lower in the intervent ion group (P <
0.001)
4The control group risk of CL in Kroeger 2002 VEN was 89 per 1000 people. For consistency with other ’Summary of f indings’
tables we used an assumed risk of 52 per 1000, which was taken f rom Reyburn 2000 AFG.
5No serious imprecision: At 12 months post intervent ion, no CL cases had been reported in the intervent ion areas, compared
to 148 in control areas.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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ITS versus no intervention for preventing leishmaniasis
Patient or population: People at risk of CL or VL
Settings: CL or VL endemic areas
Intervention: ITS
Comparison: No intervent ion
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(trials)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
No intervention ITS
Vector density - - - (1 trial) ⊕©©©
very low1,2,3,4
No data post-interven-
t ion.
CL cases
> 12 months follow-up
52 per 1000 18 per 1000
(10 to 30)
RR 0.34
(0.20 to 0.57)
2784
(1 trial)
⊕⊕©©
low2,5,6
-
VL cases
> 2 years follow-up
- - - (0 trials) - -
* The basis for the assumed risk is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed risk in the comparison group and the relative
effect of the intervent ion (and its 95% CI).
CI: conf idence interval; RR: risk rat io; CL: cutaneous leishmaniasis; VL: visceral leishmaniasis; ITS: insect icide treated bedsheet.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1One trial evaluated the ef fects of hanging ITS near to a chicken shed.
2Downgraded by 1 for serious risk of bias: Trials are at high or unclear risk of select ion bias and report ing bias.
3Downgraded by 2 for very serious indirectness: This is a single trial and does not direct ly assess the ef fects of ITS.
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4The trial authors state that ‘‘the abundance in sheds was approximately 50% below that expected on the f irst day falling to
about 80% at week 12 - the only t ime the dif ference was stat ist ically signif icant ’’.
5The assumed risk of CL over 12 months follow-up is taken f rom the control group of Reyburn 2000 AFG. This trial was
conducted in Afghanistan f rom 1997 to 1998.
6Downgraded by 1 for serious indirectness: This trial was conducted in urban areas of Afghanistan using ITS treated with
permethrin (1 g/ m²). Further trials f rom dif ferent sett ings would increase conf idence in this result .
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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Insecticide treated uniforms versus no intervention for preventing leishmaniasis
Patient or population: People at risk of CL or VL
Settings: CL or VL endemic areas
Intervention: Insect icide treated uniforms
Comparison: No intervent ion
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(trials)
Quality of the evidence
(GRADE)
Assumed risk Corresponding risk
No intervention Insecticide treated uni-
forms
Vector density - - - (0 trials) -
CL cases
> 12 months follow-up
52 per 1000 21 per 1000
(7 to 62)
RR 0.40
(0.13 to 1.20)
558
(2 trials)
⊕⊕©©
low1,2,3,4,5
VL cases
> 2 years follow-up
- - (0 trials) −
* The basis for the assumed risk is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed risk in the comparison group and the relative
effect of the intervent ion (and its 95% CI).
CI: conf idence interval; RR: risk rat io; CL: cutaneous leishmaniasis; VL: visceral leishmaniasis.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1The risk of CL in the control groups was 7% in Iran (Asilian 2003a IRN) and 13% in Colombia (Soto 1995 COL). To be
consistent with the other ’Summary of f indings’ tables, we presented an assumed risk of 5.2%.
2Downgraded by 1 for serious risk of bias: Trials are at high or unclear risk of select ion bias and report ing bias.
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3No serious inconsistency: Although, one trial reported a stat ist ically signif icant dif f erence and one does not, this is likely
related to the low CL incidence in the trial f inding no dif ference.
4No serious indirectness: In both Iran and Colombia, soldiers were randomized to wear permethrin treated uniforms
(concentrat ion of 850 mg/ m²) or standard uniforms.
5Downgraded by 1 for serious imprecision: The 95% CI of the overall ef fect is wide and includes clinically important ef fects
and no dif ference.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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Multifaceted intervention versus no intervention for preventing leishmaniasis
Patient or population: People at risk of CL or VL
Settings: CL or VL endemic areas
Intervention: Mult if aceted intervent ion
Comparison: No intervent ion
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(trials)
Quality of the evidence
(GRADE)
Assumed risk Corresponding risk
No intervention Multifaceted intervention
Vector density - - - 0 trials -
CL cases
12 months follow-up
13 per 1000 6 per 1000 RR 0.42
(0.13 to 1.41)
3631
(1 trial)
⊕©©©
very low1,2,3
VL cases
> 2 years follow-up
- - - 0 -
* The basis for the assumed risk (for example, the median control group risk across trials) is provided in footnotes. The corresponding risk (and its 95% CI) is based on the
assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: Conf idence interval; RR: risk rat io; CL: cutaneous leishmaniasis; VL: visceral leishmaniasis; ITNs: insect icide treated bednets.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1Downgraded by 1 for serious indirectness: This trial was conducted in urban areas of Colombia using a mult if aceted
intervent ion with ITNs, bars of insect repellent and permethrin painted trunks. Further studies with other combinat ion of
intervent ions and dif ferent sett ings would increase conf idence in this result .
2Downgraded by 1 for serious risk of bias: the trial is at high or unclear risk of select ion bias and report ing bias.
2
6
V
e
c
to
r
a
n
d
re
se
rv
o
ir
c
o
n
tro
l
fo
r
p
re
v
e
n
tin
g
le
ish
m
a
n
ia
sis
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
5
T
h
e
A
u
th
o
rs.
C
o
c
h
ra
n
e
D
a
ta
b
a
se
o
f
S
y
ste
m
a
tic
R
e
v
ie
w
s
p
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
o
n
b
e
h
a
lf
o
f
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
3Downgraded by 1 for serious imprecision: The 95% CI of the overall ef fect is wide and includes clinically important ef fects
and no dif ference.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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IRS versus ITNs for preventing leishmaniasis
Patient or population: People at risk of CL or VL
Settings: CL or VL endemic areas
Intervention: IRS
Comparison: ITNs
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(trials)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
ITNs IRS
Vector density - - Not pooled -
(2 trials)
⊕⊕©©
low1,2,3
One trial found a re-
duct ion in vector num-
bers post-intervent ion
and one trial did not
CL cases
> 12 months follow-up
15 per 1000 30 per 1000 RR 1.90
(0.98 to 3.69)
1655
(1 trial)
⊕⊕©©
low1,4,5,6
-
VL cases
> 2 years follow-up
- - - (0 trials) - -
* The basis for the assumed risk is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed risk in the comparison group and the relative
effect of the intervent ion (and its 95% CI).
CI: Conf idence interval; RR: risk rat io; CL: cutaneous leishmaniasis; VL: visceral leishmaniasis.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
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1Downgraded by 1 for serious risk of bias: Trials are at high or unclear risk of select ion bias and report ing bias.
2Downgraded by 1 for serious inconsistency: Chowdhury 2011 BGD reports a stat ist ically signif icant dif f erence in total vector
numbers over 12 months follow-up, Joshi 2009 ASIA found no dif ference in mean number of vectors per household.
3No serious indirectness: The trials used insect icides shown to be ef fect ive in the trial area. Trials were f rom India, Bangladesh
and Nepal.
4Downgraded by 1 for serious indirectness: There is a single trial f rom a part icular geographical area.
5No serious indirectness: This trial was conducted in urban areas of Afghanistan using lambdacyhalothrin at a target rate of
30 mg/ m². Further studies f rom dif ferent sett ings would increase conf idence in this result .
6Downgraded by 1 for serious imprecision: The 95%CI is wide and includes clinically important ef fects and no real dif f erence.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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D I S C U S S I O N
Summary of main results
We included14RCTs that evaluated a range of interventions across
different settings. All included trials were at high or unclear risk
of selection or reporting bias.
In a single trial from Afghanistan (Reyburn 2000 AFG) spraying
the internal walls of houses with insecticide reduced CL incidence
by about a third (low quality evidence), see Summary of findings
for the main comparison. In two trials from Afganistan and Iran
(Reyburn 2000 AFG; Emami 2009 IRN) ITNs reduced the inci-
dence by around two thirds (low quality evidence), see Summary
of findings 2. However, in direct comparisons between these in-
terventions (Reyburn 2000 AFG), the difference was not statis-
tically significant (low quality evidence), see Summary of findings
7. In one additional trial from Venezuela (Kroeger 2002 VEN),
ITCs almost completely prevented CL (low quality evidence), see
Summary of findings 3; and in one trial from Brazil (Kelly 1997
BRA), ITS reduced the incidence by around two thirds (low qual-
ity evidence), see Summary of findings 4.
Two small trials in soldiers evaluated personal protection for CL by
using insecticide treated clothing (Asilian 2003a IRN; Soto 1995
COL). Although there was a statistically significant effect in one
trial (Soto 1995 COL), they were both underpowered to reliably
evaluate the effects (low quality evidence), see Summary of findings
5.
Only ITNs have been evaluated for an effect on VL incidence. A
single trial from India and Nepal reported no effect (Picado 2010a
ASIA) (moderate quality evidence), see Summary of findings 2.
Two trials from Brazil evaluated the effects of culling infected
dogs versus no intervention or IRS (Costa 2007 BRA; Werneck
2014 BRA). They reported a reduction in seroconversion over 18
months follow-up but did not measure or report effects on clinical
diseases.
Some included trials evaluated vector density. Four trials (
Chowdhury 2011 BGD; Joshi 2009 ASIA; Kelly 1997 BRA;
Feliciangeli 2003 VEN) reported reductions in sandfly abundance
after spraying (moderate quality evidence). Two trials (Chowdhury
2011 BGD; Emami 2009 IRN) found a reduction in vector den-
sity after use of ITNs, while another two (Joshi 2009 ASIA;Dinesh
2008 IND) did not (low quality evidence). In one trial (Kroeger
2002 VEN), vector density was substantially lower after using
ITCs (low quality evidence).
Overall completeness and applicability of
evidence
In this Cochrane Review, most evidence relates to the use of insec-
ticide to reduce phlebotomine sandfly numbers and prevent CL.
When taken as a body of evidence, this appears to be an effective
strategy to reduce clinical disease. However, as only one or two tri-
als evaluated each individual intervention (applying insecticide to
indoor walls, bednets, bed sheets or curtains), it is unclear which
is the best strategy.
Importantly, although insecticide use appears to be effective, we
found no evidence from RCTs on the safety or environmental im-
pact of insecticides used in this way. Policy makers should con-
sider evidence from other sources when considering safety in their
decisions.
Furthermore, included trials with clinical outcomes were from
only a limited number of epidemiological settings (Afghanistan,
Iran, India, Nepal, Venezuela, Colombia and Brazil); and this lim-
its our ability to make broad generalizations. The epidemiology of
leishmaniasis is extremely complex not only because of the differ-
ent Leishmania species, vectors and reservoirs, but also because the
extreme diversity in human behaviour and settings. For example,
annual and seasonal differences in the breeding and resting habits
of infected phlebotomine sandflies, coupled with differences in
the work and recreational habits of humans are likely to affect the
efficacy of preventive measures across settings and cultures. IRS is
only considered likely to be effective where infected phlebotomine
sandflies are endophilic and the effectiveness of ITNs is considered
dependent on the local behaviour of both humans and infected
phlebotomine sandflies.
For VL, the evidence is much more limited, due in part to it being
a relatively rare disease which would require extremely large trials
to demonstrate an effect. Extrapolation of results from CL to VL
is likely to be unreliable given the differences in ecological habitats
and geographical locations.
This Cochrane Review also highlights that some widely used in-
terventions have very little evidence to support their use. There
is only a limited evidence base for the use of insecticide-treated
clothing for protection against CL transmission despite having
been used for many years by themilitary and in recreational activi-
ties as personal protection against bites. Although frequently used,
cheap and easily available, insect repellents for personal protection
against sandfly bites in endemic areas, including chemical agents
or local vegetal oils (Dhiman 1994; Kebede 2010), were not as-
sessed in any of the included trials. Very limited evidence is also
available on the effect of environmental management and modi-
fication aimed to impede phlebotomine sandflies from breeding.
The WHO recommends that sandfly control involve more than
onemethod in an integrated vectormanagement approach (WHO
2010) but only one trial with limitations in quality studied a mul-
tifaceted intervention combining ITNs, personal insect repellent,
painting of tree trunks around residences and health education
(Rojas 2006 COL).
The low number of included trials unfortunately prevented us
from conducting any subgroup analyses, which would have en-
abled analysis of the impact of different types of insecticides, resis-
tance to insecticides, the transmission seasons and vector ecology.
Although not all included trials examined the acceptability and
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compliance of the interventions, low compliance and acceptability
can represent potential limitations of the included trials.
Quality of the evidence
We judged the evidence for CL reduction with the individual
interventions (ITNs, ITS, ITCs or IRS) to be of moderate or
low quality. This means that we have some confidence in these
estimates of effect but further research is warranted.
Two main reasons led us to downgrade the evidence. Firstly, de-
scriptions of trial methods was vague for almost all included trials
and so the risk of bias was unclear, Secondly, the main evidence
was from just three trials (from Afghanistan, Venezuela and Iran),
whichmakes broad generalization to different epidemiological set-
tings and cultures difficult. To have full confidence that these in-
terventions are widely effective requires further well-conducted
trials from different settings.
Only one trial evaluated the protective effect of ITNs against VL
and found this intervention to be ineffective (Picado 2010a ASIA)
and we judged the evidence to be of moderate quality.
Potential biases in the review process
We did not identify any specific bias in our review process.
Agreements and disagreements with other
studies or reviews
A systematic review of RCTs and other controlled studies on pre-
ventative methods against human leishmaniasis (Stockdale 2012;
Stockdale 2013) was published during the development of this
Cochrane Review. The authors’ main conclusions also highlight
the lack of high quality evidence centred in clinical outcomes and
the inability to generalize the findings across different geographic
areas and settings.However, amore precisemapping of the best ev-
idence was limited because the inclusion of non-randomized stud-
ies and the lack of a methodological quality assessment of studies.
Romero 2010, a systematic review on VL control in Latin-Amer-
ica, added that lack of political commitment and the weakness of
case management and surveillance systems are important limita-
tions for VL elimination.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Using insecticides to reduce phlebotomine sandfly numbers ap-
pears to be effective at reducing CL incidence in some settings.
However, there is insufficient evidence to know whether it is better
to spray the internal walls of houses or to use insecticide impreg-
nated bednets, curtains, bedsheets or clothing. There is currently
no evidence that these measures are effective or not in reducing
VL incidence.
Policy decisions should consider local sandfly epidemiology and
behaviour, as well as the diversity of transmission scenarios (in-
cluding vector and animal or human reservoirs) when designing
and implementing leishmaniasis control programmes.
Implications for research
Resources are limited for clinical research into neglected diseases,
including leishmaniasis. Therefore, there appropriately designed
and adequately powered trials are needed.Given the link between a
reduction in phlebotomine sandfly populations and a consequent
reduction in cases of leishmaniasis is neither guaranteed or proven,
future trials of promising interventions should directly assess the
effect on reduction in cases of leishmaniasis. The use of standard
guidelines, as performed for other leishmaniasis reviews (Gonzalez
2010), may help to resolve these issues. In the case of cluster-RCTs
it is very important to obtain specialist statistical advice throughout
the entire process of planning, conducting and analysing the trials
(Bowater 2009).
Adequate exploration and reporting of acceptability and compli-
ance of intervention measures is crucial for the correct interpreta-
tion of the results assessing preventive measures, otherwise results
may not be significant for the main objective of the study.
Given the constraints of IRS, it is worth further exploring the use,
effect and impact of insecticide treated materials, particularly long
lasting insecticide treated clothes and ITNs. The gap of RCTs in
vector controlmeasures inAfrica is remarkable. There is also a need
for testing the use of different types of insecticide and their impact
in different geographical areas. We have found some additional
areas of uncertainty that need to be explored in future trials:
• Strategies of EVM.
• Multifaceted interventions.
• Integrated vector management strategies based on
understanding the local resources.
• Human and animal (domestic and wild) reservoir control
(for example, impregnated dog collars or lotions, poisonous baits
for rodents eating seeds, removal of plants for rodents which feed
on them, vaccines for canine leishmaniasis, destruction of
burrows, trapping).
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Asilian 2003a IRN
Methods Trial design: Doubled-blind, placebo-controlled RCT.
Unit of randomization: A soldier.
Number of participants: 324 male soldiers (162 each group).
Entomological data collection: Not performed.
Clinical data collection: All soldiers were visited monthly. CL diagnosis was confirmed in
every suspected lesionparasitologically usingGiemsa-staineddirect smears. If amastigotes
were not seen, the lesion was biopsied
Follow-up: 6 months.
Analysis: Analysed at individual level.
Participants Male soldiers, aged 19 to 21 years, with no history of leishmaniasis or any evidence of
active CL
Endemic disease: CL (no mention of theLeishmania species involved).
Interventions 1. Permethrin-impregnated uniforms (shirt, undershirt, pants, socks and hat; with a
permethrin concentration of 850 mg/m² of clothing), for 3 months.
2. Control uniforms (shirt, undershirt, pants, socks and hat were soaked in water
that did not contain permethrin), for 3 months.
Outcomes 1. Number of new cases of leishmania, assessed at 6 months.
2. Adverse-effects, such as contact dermatitis, were not observed in any soldiers.
Notes Country: Iran (area of Isfahan).
Trial dates: June 2001 to September 2001.
Trial sponsor: Not reported.
Sample size calculation: Not calculated.
Compliance assessment: Done. Soldiers were instructed not to use insect repellents and
other protective measures, and adherence to these instructions was monitored. The
uniforms covered the whole body except for the head, neck, hands and feet
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient detail was reported about the
method used to generate the allocation se-
quence. “A total of 324 soldiers were ran-
domly divided into two groups”
Allocation concealment (selection bias) High risk Not reported.
Blinding (performance bias and detection
bias)
participants
Unclear risk Participants were blinded but with no de-
tail of the method used for it. “The uni-
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Asilian 2003a IRN (Continued)
forms were distributed in such a way that
neither the soldier nor the researcher knew
as to which uniform were permethrin-im-
pregnated”
Blinding (performance bias and detection
bias)
investigators
Unclear risk Investigators were blinded but with no de-
tail of the method used for it. “The uni-
forms were distributed in such a way that
neither the soldier nor the researcher knew
as to which uniform were permethrin-im-
pregnated”
Blinding (performance bias and detection
bias)
Assessors
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
High risk ITT analysis was not used. Intervention:
28 dropouts (the reasons for dropouts were
not reported). Control: 24 dropouts (the
reasons for dropouts were not reported)
Selective reporting (reporting bias) Low risk All outcomes mentioned in the methods
were reported in the results
Baseline measurements High risk No baseline characteristics by group.
Statistical adjustment for clustering Low risk Not applicable as this trial was individually
randomized.
Other bias Unclear risk Trial authors did not provide a conflict of
interest declaration
They did not take into account the activ-
ities of soldiers during day and night, or
where they slept
Chowdhury 2011 BGD
Methods Trial design: Cluster-RCT.
Unit of randomization: 5 households.
Number of clusters: 6.
Entomological data collection: Adult sandfly density was determined in households
sampled monthly by counts of vectors either landing rates on exposed body parts of
humans acting as baits or collected resting inside buildings (for example, walls)
Clinical data collection: Not done.
Length of follow-up: 12 months.
Analysis: Analysed at household level.
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Chowdhury 2011 BGD (Continued)
Participants Four villages were divided into six geographical areas with high, intermediate or low
density of phlebotomine sandflies. Five households were selected from each of the density
areas by simple random sampling, yielding a subset of (24 X 5) 120 households that
participated in the trial. The assignment to intervention armswas stratified by the average
vector density to provide comparable vector density distribution in each arm
Endemic disease: VL caused by L. donovani.
Interventions 1. IRS using deltamethrin (K-Otrine 5%, Aventis Bayer company, target
concentration 20 mg/m²).
2. Long-lasting insecticide treated nets type PermaNet® 2.0 nets (second
generation, Vestergaard Frendsen Lousanne) made of polyester containing
deltamethrin (55 mg/m²).
3. EVM. Community mobilizers conducted weekly home visits and educated
household members. The major activity was filling cracks and crevices in the walls and
floors of human dwellings, detached kitchens, cattle sheds and other structures, such as
cattle troughs with mud plaster. In addition, the team promoted cleaning up debris
from the environment. Household incentives were offered, consisting of a pen, pencil
and notebook for children attending school, or soap if there were no schoolchildren in
the household.
Outcomes 1. Mean number of phlebotomine sandflies trapped per household for 12 months.
Notes Country: Bangladesh (Fulbaria subdistrict, Mymensingh district)
Trial dates: October 2006 to September 2007. Unclear timing and duration of interven-
tions
Trial sponsor: Funded by a grant from the Centers for Disease Control and Prevention
(CDC) Emerging Infections Initiative and by the Special Programme for Research and
Training in Tropical Diseases, WHO
Sample size: Calculated.
Compliance assessment: Done. Houses were visited monthly to encourage compliance
This trial is 1 of 4 parallel trials in India,Nepal, andBangladesh that used similarmethods
and design (Joshi 2009 ASIA).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient detail was reported about the
method used to generate the allocation se-
quence
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding (performance bias and detection
bias)
participants
Unclear risk People not assessed in this trial.
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Blinding (performance bias and detection
bias)
investigators
Unclear risk Not reported.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information on loss of clusters. Individ-
ual participants were not followed up
Selective reporting (reporting bias) Low risk All outcome mentioned in the methods
were reported in the results
Baseline measurements Low risk Assignment to intervention arms were
stratified by vector density
Statistical adjustment for clustering Low risk The outcome was rates of phlebotomine
sandflies trapped, and the statistical model
used a random effect which accounted for
clustering within households
Other bias Unclear risk Trial authors did not provide a conflict of
interest declaration
Costa 2007 BRA
Methods Trial design: Cluster-RCT.
Unit of randomization: Geographic area.
Number of clusters: 34 geographic areas.
Entomological data collection: Not done.
Clinical data collection: Immunological tests byELISA inblood samples to detect antigen
from Leishmania chagasi, at one year.
Length of follow-up: 6 to 12 months.
Analysis: Analysed at cluster level.
Participants The central area of Teresina (Brazil) was divided in 34 geographic areas (blocks) ran-
domly allocated to the 4 types of interventions (367 inhabitants; 213 seronegatives/154
seropositives at the beginning)
Endemic disease: VL caused by L. infantum (L. chagasi).
Interventions 1. Spraying houses and animals pens with insecticide.
2. Spraying houses and eliminating infected dogs.
3. Combination of spraying houses and animal pens and eliminating infected dogs.
4. Spraying houses (considered as no treatment in the publication).
Description of spraying: Pyrethroid insecticide in internal walls (all of 3 m height walls
were sprayed) of houses (household spraying) and outdoors close to the houses
The elimination of infected dogs was decided if indirect immunofluorescence test was
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more or equalled 1:40
Outcomes 1. Cases of seropositivity by ELISA assessed at one year.
Notes Country: Brazil (Teresina, Itararé quarter).
Trial dates: 1995 to 1996.
Trial sponsor: No source of funding reported.
Sample size: Not calculated.
Compliance assessment: Not reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient detail was reported about the
method used to generate the allocation se-
quence. “Os lotes foram alocados aleatori-
amente a 4 tipos de intervenção”
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding (performance bias and detection
bias)
participants
Unclear risk Not reported.
Blinding (performance bias and detection
bias)
investigators
Unclear risk Not reported.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
High risk No information on loss of clusters. There
were 44% of lost of participants to follow-
up (93/213) although the authors did not
specify to which group these people be-
longed
Selective reporting (reporting bias) Low risk All outcomes mentioned in the methods
were reported in the results
Baseline measurements High risk The prevalence of seropositivity at baseline
were similar in the intervention areas but
was significantly lower in the control area
(only IRS). Groups were not comparable at
baseline. Prevalence of infection was simi-
lar within the three treatments, but not be-
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tween the treatments and the control group
(lower prevalence in control group)
Statistical adjustment for clustering Low risk Cluster adjustment was performed as the
model considered the effect of aggregation
of individuals in batches and used robust
variance estimates
Other bias Unclear risk Trial authors did not provide a conflict of
interest declaration
Dinesh 2008 IND
Methods Trial design: Paired RCT.
Unit of randomization: Houses.
Number of houses: 48.
Entomological data collection: Cross-sectional surveys using one CDC light trap per
house. Collection was one night (6pm to 6am) at baseline (week 0), and then at 3, 6 and
9 weeks after net installation
Clinical data collection: Not done.
Length of follow-up: 9 weeks.
Analysis: Analysed at household level.
Participants Three hamlets in Bihar, India (Gulmehiya Bagh in Patna district, and Rasoolpur and
Majlishpur, both located in Vaishali district) were selected for this trial. In each hamlet,
16 houses were selected: 8 human dwellings without cattle inside the house but with
cattle within the compound and 8mixed dwellings where cattle and humans were sharing
the same roof. For both types of houses and in each hamlet, 2 houses were allocated to
1 of the 4 treatments)
Endemic disease: VL caused by L. donovani.
Main vector and seasonality: P. argentipes has well-defined seasonal patterns with a peak
from March to May, and a second lower peak in November
Interventions Three nets were distributed to each house after the baseline survey:
1. Olyset® ITN: Polyethelene wide mesh net (4 mm X 4 mm), impregnated with
permethrin (2%).
2. PermaNet® 2.0 ITN: Polyester net with small meshes (25 holes/cm²)
impregnated with deltamethrin (55 mg/m²).
3. Control: Untreated locally made polyester nets (25 holes/cm²).
4. Control: Untreated PermaNet® 2.0.
During the trial period, the 3 hamlets were sprayed with DDT by the Governmental
Control Programme at a dosage of 1 g active ingredient/m², between surveys 1 and 2
Outcomes 1. Geometric mean sandfly counts per group at baseline, 3, 6 and 9 weeks post-
intervention.
Notes Country: India.
Trial dates: April to June 2006.
Trial sponsor: the European Union, the Indian Council of Medical Research, the Gov-
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Dinesh 2008 IND (Continued)
ernment of India Health and FamilyWelfare, NewDelhi. The CDC light traps purchase
was sponsored by Mr Guy Deckers (Konhef, Belgium)
Sample size: Not calculated.
Compliance assessment: Not reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient detail was reported about the
method used to generate the allocation
sequence. “In each hamlet, 16 houses
were purposively selected: eight human
dwellings without cattle inside the house
but with cattle within the compound and
eight mixed dwellings where cattle and hu-
mans are sharing the same roof. For both
the categories and in each hamlet, two
houses were randomly allocated to one of
the four treatments.”
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding (performance bias and detection
bias)
participants
Low risk Individual participants not assessed in this
trial.
Blinding (performance bias and detection
bias)
investigators
Unclear risk Not reported.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk All houses were analysed. Individual par-
ticipants not assessed
Selective reporting (reporting bias) High risk Non-significant results not showed. “The
model also includes baseline survey in OT,
PT, PC allocated houses when compared
with LC ones, CDC light traps vs. aspirator
collection,mixed houses vs. humanhouses,
hamlets 2 vs. 1, and hamlets 3 vs. 1 (results
not shown).”
Baseline measurements High risk Significantly higher numbers of P. argen-
tipes males were noted during the baseline
survey in PT (IRR: 5.70; P = 0.008) and
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OT(IRR: 4.63; P = 0.028) allocated houses
than in LC houses. Larger numbers of fe-
males of Sergentomyia, mainly unfed, were
observed in OT allocated houses (IRR: 1.
96; P = 0.0480)
Statistical adjustment for clustering Unclear risk No adjustment was done. However, the
outcome was sandfly density and the anal-
ysis was conducted at the household level,
which is the unit of randomization, thus
removing any clustering effects
Other bias Unclear risk Trial authors did not provide a conflict of
interest declaration
Emami 2009 IRN
Methods Trial design: Cluster-RCT.
Unit of randomization: Urban sectors.
Number of clusters: 12 (6 pairs) sectors (7636 inhabitants in 3000 households)
Entomological data: monthly collection of phlebotomine sandflies from fixed indoors
sites and from outdoors courtyards using 30 sticky traps and 20 (unspecified) light traps,
assessed at one year
Clinical data collection: Follow-up questionnaires and examinations were conducted
every month between August 2004 and July 2005. All members of the participating
households were examined. The presence or absence of CL ulcers was indicated on the
forms
Length of follow-up: 12 months.
Analysis: Analysed at cluster level.
Participants In each city, 6 urban sectors were selected based on the pre-intervention epidemiological
survey of disease in the area so that all sectors had a similar size and distribution of
disease. Each sector in a pair was at least 2 km away from the other
Endemic disease: CL caused by L. tropica.
Interventions 1. Olyset® long-lasting permethrin Insecticide-treated nets (weigh of about 750 g
and a surface area 14 m²).
2. No ITNs.
Outcomes 1. Number of new cases of CL, assessed at one year.
2. Estimates of the density of the vectors.
Notes Country: Iran (cities of Sedeh and Shiraz).
Trial dates: April 2004 to July 2005.
Trial sponsor: This investigation received technical and financial support from theWHO
EasternMediterranean Region (EMR), Division of Communicable Diseases (DCD) and
the WHO Special Programme for Research and Training in Tropical Diseases (TDR)
: EMRO/DCD/TDR Small Grants Scheme for Operational Research in Tropical and
Communicable Diseases
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Sample size: Not calculated.
Compliance assessment:Done.Health educationalmessages were disseminated to ensure
participants’ compliance with the proper use of ITNs and that they did not use other
methods of preventingphlebotomine sandflies. To ensure correct use of ITNs, 59 training
sessions for families in the intervention group were carried out in schools and mosques.
Pre-intervention: Inhabitants of areas which most active cases of CL were recorded by
health centres, were examined and forms were completed for each household during
house-to-house visits. The interviewers examined scars and ulcers, recording cases that
occurred during the 9 months before the interview. Students in all elementary schools
were examined and questioned in the 2 cities
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”For each of the 6 pairs we used computer-
generated random numbers to allocate 1
sector to receive Olyset ITNs (intervention
group) and the other sector to receive no
nets (control group)
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding (performance bias and detection
bias)
participants
Unclear risk Not reported.
Blinding (performance bias and detection
bias)
investigators
Unclear risk Not reported.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk No information on loss of clusters. Loss to
follow-up of 11 participants (8/3818 in the
intervention group and 3/3818 in the con-
trol group)
Selective reporting (reporting bias) Low risk All outcomes mentioned in the methods
were reported in the results
Baseline measurements Unclear risk No baseline information. Questionnaire
done, but not provided
Statistical adjustment for clustering High risk No statistical adjustment for clustering was
made in the primary analysis of this cluster-
RCT
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Other bias Unclear risk Trial authors did not provide a conflict of
interest declaration
Feliciangeli 2003 VEN
Methods Trial design: Paired RCT.
Unit of randomization: Houses.
Number of houses: 40.
Entomological data collection: Sandflies were collected by CDC miniature light traps
that were suspended from the ceiling at about 2 m from the ground floor and left
overnight in the bedrooms of control and sprayed houses
Clinical data collection: Not done.
Length of follow-up: 79 days.
Analysis: Analysed at house level.
Participants Included houses were made of mixture of mud and straw supported by a structure of
sticks, called “bahareque” in the local colloquial language (24%), concrete blocks (26%)
and wood (26%)
Endemic disease: CL caused by L. braziliensis and L. mexicana.
Interventions 1. IRS using lambdacyhalothrin 10% water-dispersible powder at a dosage of 25 mg/
m². Insecticide application was made using a Hudson X-Pert hand compression sprayer
on the internal wall surface of the houses and on the lower surface of large furniture.
2. Control group (not described).
Outcomes 1. Estimates of the density of the vectors assessed at 79 days.
Notes Country: Venezuela (El Ingenio).
Trial dates: December 1996 to February 1997.
Trial sponsor: STD Programme of the Commission of the European Communities (DG:
XII: Science, Research and Development) (Contract no. TS3.CT.930247), the Consejo
de Desarrollo Cientifico y Humanístico de la Universidad de Carabobo (CDC-UC,
Project FCS-91-044), and the Dirección de Malariologia y Saneamiento Ambiental,
Ministerio de Salud y Asistencia Social, Maracay, Venezuela. One author of the trial (D.
Campbell-Lendrum) was supported by the Wellcome Trust
Sample size: Not calculated.
Compliance assessment: Not reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient details were reported about the
method used to generate the allocation se-
quence. “These were paired according to
structure and randomly assigned to the
control group (n = 20: B = 7, C = 6, and
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W = 7) or the group to be sprayed (n = 20:
B = 7, C = 7, and W = 6)”
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding (performance bias and detection
bias)
participants
Unclear risk Individual participants not assessed in this
trial.
Blinding (performance bias and detection
bias)
investigators
Unclear risk Not reported.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information if all houses were analysed.
Individual participants not assessed
Selective reporting (reporting bias) Low risk All outcomes mentioned in the methods
were reported in the results
Baseline measurements Unclear risk No baseline information. Questionnaire
done, but information not provided
Statistical adjustment for clustering Unclear risk No adjustment was done, however the out-
come was sandfly density and the analy-
sis was conducted at the household level,
which is the unit of randomization, thus
removing any clustering effects
Other bias Unclear risk Trial authors did not provide a conflict of
interest declaration
Joshi 2009 ASIA
Methods Trial design: Cluster-RCT.
Unit of randomization: Hamlets/neighbourhoods with 50 to 100 houses each
Number of clusters: 96, 24 per intervention arm.
Entomological data collection: Cross sectional estimates of the density of the vectors
using CDC light traps on 2 consecutive nights, in 5 randomly selected households in
each intervention and control cluster
Clinical data collection: Not done.
Length of follow-up: 5 to 6 months.
Analysis: Analysed at cluster level.
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Participants Villages with a high reported incidence of VL in the past 3 years were selected
Socio-economic conditions are described as comparable between sites but are not further
described
Endemic disease: VL caused by unknown L. spp.
Interventions 1. IRS: A field worker applied the insecticide to the interior walls of the house and
cattle sheds, up to 6 ft high, targeting the cracks and crevices (in Bangladesh the
exterior was also sprayed):
◦ Bangladesh: deltamethrin (target concentration 20 mg ai/m², Aventis Bayer);
◦ India: DDT 5% (target concentration 1 g/m², Hindustan Insecticide
Limited).
◦ Nepal: alpha-cypermethrine (target concentration 0.025 mg/m², Gharda
Chemical Ltd.).
2. Long-lasting ITN: Distributed to all households (“to cover all household
members”).
◦ All sites: PermaNet® nets: Polyester with small mesh (156 holes/in²),
impregnated with deltamethrin (55 mg/m²).
3. EVM: Education and supervision of activities through trained community
mobilizers to promote filling of cracks and crevices in houses and cattle sheds.
◦ Nepal and India: wall plastering with lime/mud mixture was promoted (lime
was provided free of charge);
◦ Bangladesh: wall plastering with mud only (a token incentive was provided).
4. Control: No specific vector control intervention.
Outcomes 1. Mean number of phlebotomine sandflies per household per night at baseline and
at 5 months post intervention.
Notes Country: India, Bangladesh and Nepal.
Trial dates: November 2006 to April 2007.
Trial sponsor: Special Programme for Research and Training in Tropical Diseases (TDR/
WHO). The DDT for IRS in India was donated by the Hindustan Insecticide Limited
and the LLINs (PermaNet®) for Bangladesh were donated by the Vestergaard-Frandsen
Company. The European Union FP6 INCODEV - funded KALANET project sup-
ported the LLIN trial in India and Nepal-BPKIHS
Sample size: Calculated.
Compliance assessment: “A spray field worker applied the insecticide to the interior (in
Bangladesh also to the exterior) walls of the house and cattle sheds ... Quality control
was done by the research team.”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk The selection of clusters to include in the
trial, the allocation of clusters to interven-
tion arms, and the selection of households
for entomological assessment are all de-
scribed as ’random’ but no further details
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are given
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding (performance bias and detection
bias)
participants
Low risk Individual participants not assessed in this
trial.
Blinding (performance bias and detection
bias)
investigators
High risk Investigators were not blinded.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk No clusters were lost to follow-up. Individ-
ual participants not assessed
Selective reporting (reporting bias) Low risk All outcomes mentioned in the methods
were reported in the results
Baseline measurements Low risk “Climatic conditions in the study areas
were fairly uniform, with a low vector sea-
son fromDecember to March due to lower
temperatures. Socio-economic conditions
(including age structure, the number of
people per household and the illiteracy
rate) and disease awareness was comparable
in each of the study sites”
Baseline measurements of mean phle-
botomine sandflies per household were not
significantly different at baseline
Statistical adjustment for clustering Low risk “Multilevel modelling with sample clus-
ters (hamlet/neighbourhood) as the second
level of clustering was applied. The Pois-
son-regression procedure in STATA 10.1,
with a robust sandwich estimator for clus-
tering, was used in the analysis.”
Other bias High risk Trial authors declared no competing inter-
ests. The role of the founder is not clarified
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Methods Trial design: Cluster-RCT.
Unit of randomization: Homestead with a single chicken shed.
Number of clusters: 30 houses randomized to three arms.
Entomological data collection: 5 CDC light traps in each cluster (3 in the house, 1 in
the chicken shed and 1 in the dining hut) set from 18.00 to 06.15. Nine rounds of
collections: 2 pre-intervention and 7 post-intervention; approximately 2 weeks apart
Clinical data collection: Not done.
Length of follow-up: 7 months.
Analysis: Analysed at cluster level.
Participants 30 homesteads with chicken sheds were selected for the trial. After two pre intervention
phlebotomine sandflies trapping rounds (4 weeks), each chicken shed of a group was
randomly assigned to one of three treatments: spray, target or control (no insecticide)
Endemic disease: VL caused by L. chagasi (L. infantum).
Interventions 1. IRS. Walls and roof, inside and out, of each chicken shed sprayed with
lambdacyhalothrin (20 mg/m²; Icon 10% ME).
2. ITS. Sheets treated with lambdacyhalothrin (20 mg/m²) installed 1 m from the
roost.
3. Control. No intervention
(One homestead received all the interventions but we excluded it as it was not a ran-
domized comparison)
Outcomes 1. Geometric mean abundance of Lu. longipalpis in the houses (all three traps
combined), the chicken shed and the dining-hut, measured at 3 and 7 months.
Notes Country: Brazil (conducted in 7 villages: Campinas, Pingo d’Agua, Estrada, Vila Ceará,
Vila da França, Vila Nova and Bacabau)
Trial dates: November 1993 to June 1994.
Trial sponsor: A research studentship from theMedical ResearchCouncil and aChadwick
TrustTravellingFellowship, theBrazilianFundaçaoNacional de Saude. Insecticide for the
project was donated by Zeneca Saude Pública, Brasil. Facilities at the Instituto Evandro
Chagas through BelBm Research Projects. Field expenses from the Brazilian Fundaçao
Nacional de Saúde
Sample size: Not calculated.
Compliance assessment: Not reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient detail was reported about the
method used to generate the allocation se-
quence. “each chicken shed of a group was
randomly assigned to one of three treat-
ments: spray, target or control (no insecti-
cide).”
Allocation concealment (selection bias) Unclear risk Not reported.
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Blinding (performance bias and detection
bias)
participants
Low risk Individual participants not assessed in this
trial.
Blinding (performance bias and detection
bias)
investigators
Unclear risk Not reported.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information on loss of clusters. Individ-
ual participants not assessed
Selective reporting (reporting bias) Low risk All outcomes mentioned in the methods
were reported in the results
Baseline measurements Unclear risk No baseline information.
Statistical adjustment for clustering Unclear risk No adjustmentwas done, however, the out-
come was sandfly density and the analy-
sis was conducted at the household level,
which is the unit of randomization, thus
removing any clustering effects
Other bias Unclear risk Trial authors did not provide a conflict of
interest declaration.The role of the founder
is not clarified
Kroeger 2002 VEN
Methods Trial design: Cluster-RCT.
Unit of randomization: City sectors.
Number of clusters: 14.
Entomological data collection:Cross sectional estimates of the density of the vectors using
light traps in the main room of 565 houses for 150 nights at baseline (pre-intervention)
and during the three months after the intervention (post-intervention)
Clinical data collection: Cross sectional questionnaire survey of 569 houses with 2913
inhabitants plus examination for past or current CL (pre-intervention) at baseline and
repeated at 12 months post-intervention
Length of follow-up: 12 months.
Analysis: Analysed at individual (population) and cluster level (sector/houses)
Participants Baseline data on 2913 people living in 569 houses, follow-up data on similar number.
(The original sample size was 578 but 1.6% did not respond). The population was
described as having moderate levels of poverty, 31% < 15 years old, 9% > 60 years old,
average of 5 people per household, 21% were engaged in domestic activities, 21% were
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students, 13% were manual workers, self employed artisans, or secretaries, 7% were
unemployed, 7% had an academic profession, and only 2% were farmers
Estimated annual incidence of leishmaniasis: 0.5% or above.
Endemic disease: CL caused by unknown Leishmania spp (main vector: Lu. youngi
and Lu. ovallesi).
Interventions 1. ITCs. The windows of all houses were covered with polyester curtains (mesh size:
0.05 mm), impregnated with lambdacyhalothrin (12.5 mg/m²; ICON 2.5CS,
Syngenta, Basle) at baseline and at 6 months.
2. Control. 7 sectors had unimpregnated curtains and 1 randomly selected sector
had no curtains.
Outcomes 1. Number of new cases of CL assessed at 12 months.
2. Mean number of houseflies per traps per night pre and post intervention.
Notes Country: Venezuela (Trujillo).
Trial dates: January 2000 to August 2001.
Trial sponsor: Funded by the European Commission (contract Alfa Programme 600119
and INCODEV IC18CT 980339). The insecticide was donated by Syngenta
Sample size: Not calculated.
Compliance assessment: Not reported.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “For each of the seven matched pairs we
randomly allocated one sector (using com-
puter created random numbers) to the in-
tervention group and the other to the con-
trol group”
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding (performance bias and detection
bias)
participants
High risk “the population being “blind” towards the
group allocation”. One sector did not re-
ceive unimpregnated curtains so would be
aware of their allocation
Blinding (performance bias and detection
bias)
investigators
Unclear risk Not reported.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk This was not stated.
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Incomplete outcome data (attrition bias)
All outcomes
Low risk No clusters were lost. The final number of
participants were increased in 25 persons
(see below). ITT analyses and dropouts per
group and reasons described
Selective reporting (reporting bias) Unclear risk Not reported.
Baseline measurements Unclear risk Only number cases (%) of CL and mean
number of phlebotomine sandflies per
traps captured, at baseline (other info not
provided by groups)
Statistical adjustment for clustering High risk No statistical adjustment for clustering was
performed in the primary trial. However,
sensitivity analysis was done at a range of
ICCs in this review and it was concluded
that if the ICC had been as high as 0.05,
the CIs would have crossed over 1
Statistical analysis: The trial authors used
EpiInfo, SPSS, and Stata v6 for analy-
sis. Before the main analysis: Fisher’s ex-
act tests to compare cumulative incidence
between intervention and control sectors
for each pair. They used cumulative inci-
dence rates of CL and the average num-
ber of flies per trap (house) for each sec-
tor as the units of analysis. They compared
data at baseline and then at follow-up be-
tween the intervention and control groups
using a paired t test, weighting the data ac-
cording to the sector size. They also used
Wilcoxon’s matched pairs test because the
small number of pairs made it difficult to
assess whether the underlying distribution
of the differences was normal (necessary for
the validity of the t test), and theWilcoxon
test does not require this assumption. Dif-
ferences rather than ratios are presented as
the estimates of effect because zeroes for the
main outcome, CL, precluded the use of
ratios
Other bias Unclear risk Trial authors declared no competing inter-
ests. The founders had no role in the trial
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Methods Trial design: Cluster-RCT.
Unit of randomization: Hamlets.
Number of clusters: 26 (13 intervention and 13 control clusters; 12,691 people)
Entomological data collection: Done in Picado 2010b, an excluded non-randomized
entomological study based in this trial
Clinical data collection:
• Cases of VL were double checked with patients’ records. Suspected people were
examined by a physician who was blinded to the status of the cluster and tested with a
rapid Kalazar Detect Rapid Test and classified as probable or certain VL.
Asymptomatic infections were clinically followed up for a minimum of six months.
Trained field workers carried out verbal autopsies on all deaths recorded during the
trial. Two independent physicians ascertained cause of death.
• L. donovani infections as measured by seroconversion with the direct
agglutination test at 12 and 24 months after the intervention, November to December
2007 and 2008, respectively. Seroconversion was considered only in people who had
negative results on the direct agglutination test (≤ 1:800) in the baseline survey (or
their first blood sample).
Length of follow-up: 30 months (from November 2006 to May 2009) for cases of VL
and 12 to 24 months after the intervention for seroconversions
Analysis: Analysed at cluster level.
Participants Clusters were paired on the basis of incidence of VL between 2003 and 2005
Eligibility criteria: In May 2006, they selected and included in the trial 26 (16 in India,
10 in Nepal) high incidence clusters out of 34 clusters with a high number of reported
cases of VL (22 in India, 12 in Nepal) based on the following criteria:
• At least one case of VL in 2003, 2004, and 2005, indicating continuous L.
donovani transmission.
• A minimum 0.8% average annual incidence rate of VL from 2003 to 2005.
• A population ranging from 350 to 1500 people.
• A minimum distance of 1 km between clusters.
The 26 clusters were stratified by country (16 in India and 10 in Nepal) and population
size (6 and 4, respectively, having over 710 residents) and then paired by previous average
incidence rate of VL. Clusters in each pair were randomly allocated to group 1 or 2. The
random selection of clusters into groups was undertaken in Excel (Microsoft), and the
difference in the total number of cases of VL reported in the past three years between
group 1 and 2 had to be less than 10%
All individuals living for at least six months a year in the clusters were eligible, but blood
sampling was restricted to individuals aged over 2 years
Endemic disease: VL caused by L. donovani.
Interventions 1. Longlasting ITNs (PermaNet® 2.0, treated with deltamethrin 55 mg/m²;
Vestergaard-Frand- sen, Denmark; 75 denier, 25 holes/cm² coated fibres). Distributed
in December 2006.
2. No intervention as control. The control clusters were allowed to continue using
any existing conventional strategies for personal protection. They were not provided
with ITNs nor was the use of untreated nets promoted.
Outcomes 1. Number of new cases of VL assessed at quarterly bases for 30 months.
2. Presence of the parasite by seroconversion with the direct agglutination test
assessed at 12 and 24 months after the intervention.
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Notes Country: India (Muzaffarpur district) and Nepal (Sunsari, and Morang districts)
Trial dates: November 2006 to May 2009.
Trial sponsor: Funded by the European Union under its 6th Framework Program (IN-
CODEV/Project 015374). Contract no INCO-CT 2005-01537, KALANET project
Sample size: Calculated.
Compliance assessment: Done. “In intervention clusters, 8920/9829 (91%) of the in-
dividuals slept regularly (that is, over 80% of the nights) under a treated net. Those
observations were confirmed by an additional acceptability survey (V Vanlerberghe, per-
sonal communication, January 2010). The use of untreated nets in the control group
was variable; 7012/9981 (70%) used a bed net at least once during the trial but only
2978/9981 (30%) used it regularly throughout the year as most of the households did
not have enough nets for all their members.”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The intervention was then randomly allo-
cated to one of the groups by tossing a coin
in the presence of observers.”
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding (performance bias and detection
bias)
participants
Unclear risk This was not stated.
Blinding (performance bias and detection
bias)
investigators
Unclear risk This was not stated.
Blinding (performance bias and detection
bias)
Assessors
Low risk “All clinically suspected cases detected dur-
ing the trial were classified as probable or
certain visceral leishmaniasis by a clinician
who was blinded to the status of the clus-
ter”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No clusters were lost to follow-up. Anal-
yses and dropouts per group and reasons
described. The proportion of people lost
to follow-up (not present or with one
or no blood sample) was slightly higher
in the control group (21%, (644 +1466)
/9981) than in the intervention group
(19%, (545+1347)/9829). But the charac-
teristics of the participants lost to follow-
up in both groups were similar (mean age
22 v 23, males 62% v 63%, mean socioe-
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conomic status 2.0 v 2.2, in intervention
and control groups respectively)
Selective reporting (reporting bias) Low risk All outcomes mentioned in the methods
were reported in the results
Baseline measurements Low risk Yes (table). Intervention and control groups
were well balanced at individual and clus-
ter levels, but the prevalence of positive re-
sults on the direct agglutination test at base-
line in India was almost twice as high as
in Nepal, despite the previous annual inci-
dence of VL being similar
Statistical adjustment for clustering Low risk Data were analysed at the cluster level. No
adjustment for clusteringneeded as analysis
was done at the cluster level
Other bias Low risk Trial authors declared no competing inter-
ests. The trial founder had no role in the
trial design, data collection and analysis, in-
terpretation or reporting of this work, or
the decision to submit the work for pub-
lication. Competing interests: All authors
completed the Unified Competing Interest
form and declared: “no support from any
organisation for the submitted work; no
financial relationships with any organisa-
tions that might have an interest in the sub-
mitted work in the previous three years, no
other relationships or activities that could
appear to have influenced the submitted
work”
Reyburn 2000 AFG
Methods Trial design: Cluster-RCT.
Unit of randomization: Blocks of 10 houses.
Number of clusters: 957.
Entomological data collection: Not done.
Clinical data collection: Cross-sectional questionnaire survey of all houses and examina-
tion for current or past CL pre-intervention and at 8, 10 and 15 months post-interven-
tion
Length of follow-up: 15 months.
Analysis: Analysed at cluster level.
Participants The population is described as being ’previously lowermiddle-class’ in a suburb of Kabul,
with houses mostly made from mud or brick. There was no evidence of prior bednet use
in the area. The mean age, sex distribution, and prevalence of old and current CL was
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similar between groups at baseline
Endemic disease: Anthroponotic CL caused by L. tropica.
Interventions 1. IRS. Sprayed with 30 mg/m² lambdacyhalothrin.
2. ITNs. Family sized polyester nets (156 holes per square inch) impregnated with 0.
5 g/m² permethrin.
3. ITS. Families supplied their usual bedsheet (usually a chaddar - head covering
clothes - or a similar piece of cotton cloth), which was impregnated with permethrin (1
g/m²: Imperator 25 EC, Zeneca) plus instructions not to wash it.
4. Control. Households were offered a 1O-s aerosol spray using a 1:50 solution of
permethrin delivered from a knapsack motorized aerosol into the centre of their living
and sleeping rooms. The estimated deposition rate was < 0.5 mg/m².
Outcomes 1. Number of new CL cases at 8, 12 and 15 months.
Notes Country: Afghanistan (Karte-Naw area of Kabul).
Trial dates: May 1997 to August 1998.
Trial sponsor: Norwegian Church Aid, the European Commission (ECHO), WHO/
UNDP/WB Special Programme for Research and Training in Tropical Diseases (project
no. 960662), the Department for International Development (UK), and HealthNet
International
Sample size: Calculated.
Compliance assessment: Done. “All the trial houses were re-visited and the household
head (mother or father) was asked 3 questions: ’have you noticed less biting by insects
this year?’, ’are you generally satisfied with the (intervention)?’ and ’would you be willing
to pay for this service in the future?’. A simple yes-no response was recorded. Direct
observation of bednet compliance or sleeping habits was not socially acceptable”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient detail was reported about the
method used to generate the allocation se-
quence. “interventions were randomly al-
located to houses within each block”
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding (performance bias and detection
bias)
participants
High risk Participants were not blinded.
Blinding (performance bias and detection
bias)
investigators
High risk Investigators were not blinded.
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Blinding (performance bias and detection
bias)
Assessors
Low risk Outcome assessors were blinded. “Survey
workers were blinded as to the intervention
received by households, having been pro-
vided with a survey form that was blank
except for the address, and were instructed
to ask respondents not to reveal the type of
intervention during the interview.”
Incomplete outcome data (attrition bias)
All outcomes
High risk No information on loss of clusters. ITT
analysis was not used. Loss to follow-up of
45% of participants, 7565 persons in to-
tal. although they did not specify the group
this people belong
Selective reporting (reporting bias) Low risk All outcomes mentioned in the methods
were reported in the results
Baseline measurements Low risk Baseline information: participants mean of
age, % of male and female, % of people
with CL active or past, and location of le-
sions
Statistical adjustment for clustering Low risk Data were cluster adjusted using a random-
effects logistic regression model
Other bias Unclear risk Trial authors did not provide a conflict of
interest declaration
Rojas 2006 COL
Methods Trial design: Cluster-RCT.
Unit of randomization: Villages.
Number of clusters: 20 villages (3631 people).
Entomological data collection: Not performed.
Clinical data collection:
• Participants were examined for scars or active skin lesions suspected to be
American CL, using clinical criteria defined in a trial (Weigle 1993).
• The leishmanin skin test was applied to detect prior Leishmania infection. The
status of community participation in each village was assessed and quantified using a
community participation unpublished score.
Length of follow-up: 12 months.
Analysis: Analysed at cluster level.
Participants Villages were paired according to prevalence of leishmanin skin test positive in children
< 5 years old, number of inhabitants, and community participation score. One village
in each pair was randomly assigned to receive the intervention; the other remained as a
control
Endemic disease: CL caused by L. braziliensis and L. panamensis.
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Interventions 1. New polyester bed nets (11.6 m² and 35 holes per cm²) were provided to all the
participants after being impregnated with K-Othrine E-25® (deltamethrin). Two bars
of the repellent Nopikex (20% DEET and 0.5% permethrin) were delivered to each
residence. Tree trunks that could serve as resting sites for phlebotomine sandflies and
were located < 50 m from an inhabited residence were painted with whitewash to a
height of 1.5 m from the ground.
2. Control villages did not receive any of the studied interventions, but like the
intervention villages, they were subject to active surveillance and case management of
American CL cases. Both for 12 months approximately. Every three months the bed
nets were impregnated, additional repellent supplied, and the tree trunks repainted.
Outcomes 1. Number of new CL cases at 12 months.
2. Presence of the parasite by leishmanin skin at the beginning of the trial and at 12
months.
Notes Country: Colombia (Tumaco, Nariño department).
Trial dates: October 1994 to June 1997.
Trial sponsor: WHO Research Training Grant and supported by the International De-
velopment Research Centre of Canada, IDRC file 92-0223-01. It included an educa-
tional programme designed and implemented by the Centro de Investigaciones Multi-
disciplinarias en Desarrollo (CIMDER) that included information about American CL,
its mode of transmission and how to use the different preventive measures accompanied
the preventive measures
Sample size: Not calculated.
Compliance assessment: “Frequency of bednet use was high and consistent during the
study. Among the participants who were interviewed during the first and second moni-
toring visits, 93% and 96% respectively reported sleeping under the bednet every night.
This was confirmed during the two unannounced visits to the residences, where approxi-
mately 85% of the bednets were in use by the participants. Because there was not enough
variation we could not evaluate dose effect for bednet use. Four of the intervention vil-
lages only had three impregnation sessions due to logistical constraints. Complete ad-
herence to the impregnation schedule, defined as the percentage of bednets that received
all the impregnations (4 or 3 depending on the village), varied among villages (17%-
100%) (data not presented). Very few participants abstained from washing their bed-
nets between two impregnations. Seventythree percent of the participants reported they
washed the bednets three or more times during that period (approximately 3 months).”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomization was performed using a
lottery system.”
Allocation concealment (selection bias) High risk “Randomization...was carried out with the
participation of delegates from the 20 vil-
lages.”
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Blinding (performance bias and detection
bias)
participants
Unclear risk Not reported.
Blinding (performance bias and detection
bias)
investigators
Unclear risk Not reported.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No clear information on loss of clusters
(“four of the intervention villages only had
three impregnation sessions due to logisti-
cal constrains”). ITT analysis was not used.
There were losses to follow-up, but the
drop-outs were excluded from the begin-
ning of the trial to analyse the results. Con-
trol group: thirteen persons excluded be-
cause they moved to an intervention vil-
lage during the follow-upperiod.Nomove-
ments in the opposite direction were doc-
umented. Absence from the village on the
days of the post-intervention exam was
somewhat more common in the interven-
tion group (no numbers)
Selective reporting (reporting bias) Low risk All outcomes mentioned in the methods
were reported in the results
Baseline measurements High risk In general, the trial groups were compara-
ble in the distribution of behavioral and oc-
cupational risk factors, but differed in the
distribution of those factors related with
the residence and the village. Residences in
the control group were more likely to be
located at the periphery, close to the forest,
have roof made of thatch, have incomplete
external walls and havemore animals. Also,
control villages had lower community par-
ticipation scores. On the other hand, vil-
lages in the intervention grouphad a greater
prevalence of infection in children < 5 years
old, had a larger number of inhabitants and
had a slightly higher number of males
Characteristics of the residence (distance to
the forest < 50 m, and roof made of thatch)
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and the village (prevalence of infection in
children < 5 years old, and community par-
ticipation score < 50) were strongly associ-
ated with American CL in this setting. Sev-
eral behavioural and occupational activities
were moderately associated with infection,
as were characteristics of the residence (roof
made of thatch and walls made of bamboo)
and the village (prevalence of infection in
children < 5 years old, and community par-
ticipation score < 50)
Statistical adjustment for clustering Low risk Generalised estimating equations were
used to adjust for clustering within villages
using an exchangeable correlation matrix
Other bias Low risk Trial authors declared no competing inter-
ests.
Soto 1995 COL
Methods Trial design: Double-blind, placebo-controlled RCT.
Unit of randomization: A soldier.
Number of participants: 286 soldiers (143 in each group).
Entomological data collection: Not done.
Clinical data collection: Medical examination. Definitive diagnosis was made by staining
a lesion smear withGiemsa andwith antileishmanial monoclonal antibodies for detecting
amastigotes. If not seen the lesion was biopsied and stained for amastigotes and cultured
for promastigotes. If promastigotes detected, they were identified to the species level with
the use of isoenzyme electrophoresis
Length of follow-up: 12 weeks.
Analysis: Analysed at individual level.
Participants Members of the Colombian army scheduled for patrol in the leishmaniasis-endemic area
of Magdalena Medio with no history of having leishmaniasis and no current signs of
infection
Endemic disease: CL caused by L. panamensis.
Interventions 1. Permethrin-impregnated uniforms (shirt, undershirt, pants, socks and hat; were
soaked in a solution containing 1 sachet (15 mL) of permethrin (gift of AgrEvo, UK;
cis : trans isomer ratio 25:75) per 2 L of water for 2 min, then air-dried for 2 to 4h,
resulting in a permethrin concentration of 850 mg/m2 of clothing).
2. Control uniforms (shirt, undershirt, pants, socks and hat; were soaked in water
that did not contain permethrin).
Outcomes 1. Number of new cases of leishmania, assessed at 12 weeks.
2. Adverse effects (two participants in the intervention group reported irritation and
pruritus).
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Notes Country: Colombia.
Trial dates: Unknown.
Trial sponsor: AB Foundation, Chevy Chase, Maryland, USA, and Rousel Uclaf/Sova
de Colombia S.A., Santafe de Bogota, Colombia
Sample size: Not calculated.
Compliance assessment: Not done. Adherence to instructions (how to use and wash
uniforms) was not monitored. “Because the purpose of the study was to determine the
efficacy of permethrin impregnation under conditions of normal duty, adherence to these
instructions was not monitored”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient detail was reported about the
method used to generate the allocation se-
quence. “All troops were randomised”
Allocation concealment (selection bias) High risk Not reported.
Blinding (performance bias and detection
bias)
participants
Unclear risk Participants were blinded. “The uniforms
were distributed in such a way that the par-
ticipants (soldiers)...did not know which
uniforms had been treated with perme-
thrin”
Blinding (performance bias and detection
bias)
investigators
Unclear risk Investigators were blinded. “The uniforms
were distributed in such a way that...the
medical attendants did not know which
uniforms had been treated with perme-
thrin”
Blinding (performance bias and detection
bias)
Assessors
Unclear risk This was not stated.
Incomplete outcome data (attrition bias)
All outcomes
Low risk ITT analysis was used. No dropouts.
Selective reporting (reporting bias) Low risk All outcomes mentioned in the methods
were reported in the results
Baseline measurements Unclear risk Baseline information: participants were
male soldiers.
Statistical adjustment for clustering Low risk Not applicable as this trial was individually
randomized.
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Other bias Unclear risk Trial authors did not provide a conflict of
interest declaration
Werneck 2014 BRA
Methods Trial design: Cluster-RCT.
Unit of randomization: Geographic area.
Number of clusters: 40 geographic areas.
Entomological data collection: Not done.
Clinical data collection: Conversion of the Montenegro skin test (MST) at 18 months
of follow-up
Length of follow-up: 18 months.
Analysis: Analysed at cluster level.
Participants Ten localities in 7neighbourhoods of the city ofTeresina (Brazil) were divided into blocks,
each containing an average of 60 residences. For each locality, 4 blocks were selected
to minimize the risk of cross-contamination of interventions. Eligible participants were
residents of selected blocks aged 1 year or above with no history of VL. The 40 geographic
areas (blocks) randomly allocated to the 4 types of interventions (697 subjects MST-)
Endemic disease: VL caused by L. chagasi (L. infantum).
Interventions 1. Spraying households and residential annexes with insecticide.
2. Elimination of infected dogs.
3. Combination of spraying and eliminating infected dogs.
4. No intervention.
Description of spraying: performed according to the routine of the VL Control Program
of the Zoonosis Control Center of the Teresina City Health Department. Interventions
were delivered in the selected blocks every 6 months, for three times, beginning just
after each household visit. The elimination of infected dogs was decided if indirect
immunofluorescence test was more or equalled 1:40
Outcomes 1. Cases of infection by L. infantum at 18 months determined by conversion of the
MST (MST- at the beginning) or diagnosis of active VL.
Notes Country: Brazil (Teresina, Itararé quarter).
Trial dates: January 2004 to December 2006.
Trial sponsor: Funded byHealth SurveillanceUnit from the BrazilianMinistry ofHealth.
One author was partially funded by the Brazilian Research Council (CNPq 306267/
2010-1 and 202088/2012-0). The founders had no role in trial design, data collection
and analysis, decision to publish, or preparation of the manuscript. The authors have
declared that no competing interests exist
Sample size: Calculated.
Compliance assessment: Not reported.
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk “Allocation was performed as follows: (a)
for each locality, a number was assigned to
each block, (b) the intervention schemes
were ordered as described above, and (c)
using the command ”sample“ in Stata, the
first block sampled was allocated to inter-
vention (i), the second to intervention (ii)
and so on. At the end, each intervention
schemewas allocated to a total of ten blocks
throughout the ten selected localities.”
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding (performance bias and detection
bias)
participants
Unclear risk Not reported.
Blinding (performance bias and detection
bias)
investigators
Unclear risk Not reported.
Blinding (performance bias and detection
bias)
Assessors
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information on loss of clusters. “Losses
to follow-up varied from 35.7% to 40.7%
between intervention groups, but no sta-
tistically significant difference was found
comparing each intervention group with
the control group (all P values >0.3).”
Selective reporting (reporting bias) High risk The trial authors’ original plan was to use
IFAT test at 6 and 12 months, but due to
operational problems, data on IFAT results
were not considered valid for the analysis,
and serology was not used as a marker of
infection in the trial. Problems with serol-
ogy were poor sensitivity and reproducibil-
ity (“For instance, among the 951 subjects
for which an IFAT result was available at
baseline, only 16 (1.68%) were positive”)
. The authors decided not to use IFAT re-
sults in the trial and relied on conversion
of the MST at 18 months of follow-up as
the only outcome measure, since no clin-
ical cases of VL were detected among the
studied population
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Baseline measurements Unclear risk A table shows the distribution of selected
baseline socio-demographic and environ-
mental characteristics for each interven-
tion group. The dog culling groups showed
“higher mean years of living in the resi-
dence and a smaller percentage of house-
holds with a chicken shed in the peri-do-
mestic environment as compared to the
control group (P < 0.015 and P < 0.046,
respectively). No other statistically signifi-
cant difference with any variables or groups
was detected.”
Statistical adjustment for clustering Low risk “Using Poisson population-average models
from generalized estimating equations with
robust variance, an exchangeable correla-
tion model, and designating each block as
the clustering level”
Other bias Low risk Trial authors declared no competing in-
terests. The trial was funded by Health
Surveillance Unit from the Brazilian Min-
istry of Health. GLW was partially funded
by the Brazilian Research Council (CNPq
306267/2010-1 and202088/2012-0). The
founders had no role in trial design, data
collection and analysis, decision to publish,
or preparation of the manuscript
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Alexander 1995a Laboratory and field-exposure (with pair of volunteers) experiments (no assessment in natural condi-
tions)
Alexander 1995c Cluster quasi-RCT: assignment to each treatment to the houses was made randomly on the first night
and then rotated sequentially from house to house
Asilian 2003b Duplicate of Asilian 2003a IRN.
Boulware 2005 This study focused on general mosquito bites, not leishmaniasis
Das 2007 Only preferences between two different kinds of LLIN.
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Das 2014 Entomological study of cows placed under different nets in cattle sheds
Davies 2000 Some houses within each village were allocated on the basis of pre-intervention sandfly or epidemio-
logical data
Gavgani 2002 Cluster quasi-RCT: villages were randomly assigned to the intervention or control group; subsequent
pairs were then assigned alternately to either the intervention or control
Jalouk 2007 Cluster quasi-RCT: villages were randomly assigned to the intervention or control group; subsequent
pairs were then assigned alternately to either the intervention or control
Kumar 1995 Cluster quasi-RCT: authors randomly selected 10 houses from a village for the intervention group, but
for the control group they used 5 houses separated from the intervention houses by approximately 450
m
Mondal 2008 Only an assessment about preventionmethods used against leishmaniasis in 9 kala-azar endemic districts
Moosa-Kazemi 2007 Treatments were randomly performed in the corresponding districts but all households enrolled in
district Shaghayegh received ITNs and ITCs; Households in district Honar received non-impregnated
bed nets and curtains and district Vakilabad was the control area
Nadim 1995 Only one cluster in each group.
Nieves 2008 Evaluation about knowledge and practices against leishmaniasis.
Picado 2010b Based on an included paired cluster-RCT (Picado 2010a ASIA) were each group were randomly allo-
cated to ITNs or control, in this excluded trial the design was not random as mentioned in the paper.
“Out of the 26 KALANET clusters, 3 intervention and 3 control clusters in each country were selected
for the entomological trial on the basis of year round accessibility and VL incidence rates. 13 clusters
were initially assessed (6 in India and 7 in Nepal) and one was finally excluded in Nepal. Being a subset
of the KALANET clusters, the 12 selected clusters for the entomological trial were not necessarily
paired.”
Rodríguez-Villamizar 2006 It is not as trial. It is an assessment on the impact of a basic health plan for preventing CL in rural areas
of Colombia
Tayeh 1997 Allocation not randomized, “the villages were randomly assigned as intervention or control villages
based on the prevalence and size of the villages. H and SN were considered an intervention villages, TS
and KS as control villages.”
Yaghoobi-Ershadi 2006 Unclear trial design. “Three villages (called Komshecheh, Aliabad-Mollaali, and Habibabad) were
selected randomly in the rural district of Borkhar, Isfahan province, central Iran. Then, in each village,
168 households near each other with similar prevalence (2.1- 2.7% for lesions and 70.4-81.2% for
scars) were recruited to the study. Treatments were randomly performed in corresponding villages. All
households enrolled in Habibabad received impregnated bed nets and curtains (IBs and ICs); Aliabad-
Mollaali, non-impregnated bed nets and curtains (NIBs and NICs) and Komshecheh was decided to
be the control area.”
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NCT01644682
Trial name or title Replacement of Insecticides to Control Visceral Leishmaniasis
Methods Allocation: randomized, endpoint classification: efficacy study, intervention model: factorial assignment,
masking: open label, primary purpose: prevention
Participants Inclusion criteria
• Household head who agree to participate in the study.
Exclusion criteria
• Household head who does not agree to participate in the study.
Interventions Interventions
A: IWFPL: Indoor house walls and floors will be plastered with lime (a traditional method known in the
study areas) including treatment of outdoor breeding places with lime and bleaching powder to inhibit sandfly
breeding;
B: IDWL: Install durable wall lining containing deltamethrin to kill immature stage and as well as adult
phlebotomine sandflies;
C: ITN: Impregnation of existing bednets available in the community with slow release insecticide,
deltamethrin
Control intervention
D: Control group, no intervention.
Outcomes Primary outcome
1. Measurement of efficacy of interventions
Secondary outcome
1. Estimation of intervention costs and its acceptability
For all outcomes, assessments were at 12 months.
Starting date May 2012
Contact information Dinesh Mondal, MBBS, MD, PhD
Telephone: +8801712027091
Email: din63d@icddrb.org
Notes
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D A T A A N D A N A L Y S E S
Comparison 1. IRS versus no intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 CL cases 1 Risk Ratio (Fixed, 95% CI) Subtotals only
1.1 8 months after
intervention
1 2943 Risk Ratio (Fixed, 95% CI) 0.47 [0.23, 0.99]
1.2 10 months after
intervention
1 2954 Risk Ratio (Fixed, 95% CI) 0.42 [0.23, 0.78]
1.3 15 months after
intervention
1 2892 Risk Ratio (Fixed, 95% CI) 0.61 [0.38, 0.97]
2 Seroconversion (Montenegro
Skin Test)
1 295 Risk Ratio (Fixed, 95% CI) 0.86 [0.63, 1.17]
2.1 18 months after
intervention
1 295 Risk Ratio (Fixed, 95% CI) 0.86 [0.63, 1.17]
Comparison 2. ITNs versus no intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 CL cases 2 Risk Ratio (Fixed, 95% CI) Subtotals only
1.1 8 months after
intervention
1 3142 Risk Ratio (Fixed, 95% CI) 0.31 [0.15, 0.66]
1.2 10 months after
intervention
1 3092 Risk Ratio (Fixed, 95% CI) 0.35 [0.20, 0.64]
1.3 > 12 months after
intervention
2 10579 Risk Ratio (Fixed, 95% CI) 0.31 [0.18, 0.53]
2 VL cases 1 19810 Risk Ratio (Fixed, 95% CI) 0.99 [0.46, 2.15]
3 Seroconversion 1 19810 Risk Ratio (Random, 95% CI) 0.90 [0.49, 1.65]
Comparison 3. ITC versus untreated curtains or no curtains
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 CL cases 1 2938 Risk Ratio (Fixed, 95% CI) 0.00 [0.00, 0.49]
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Comparison 4. ITS versus no intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 CL cases 1 Risk Ratio (Random, 95% CI) Subtotals only
1.1 8 months after
intervention
1 2918 Risk Ratio (Random, 95% CI) 0.45 [0.25, 0.82]
1.2 10 months after
intervention
1 2847 Risk Ratio (Random, 95% CI) 0.36 [0.19, 0.68]
1.3 15 months after
intervention
1 2784 Risk Ratio (Random, 95% CI) 0.34 [0.20, 0.57]
Comparison 5. Insecticide treated uniforms versus no intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 CL cases 2 558 Risk Ratio (M-H, Random, 95% CI) 0.40 [0.13, 1.20]
Comparison 6. Reservoir control versus no intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Serconversion (Montenegro Skin
Test)
1 Risk Ratio (Fixed, 95% CI) Subtotals only
1.1 18 months after
intervention
1 376 Risk Ratio (Fixed, 95% CI) 0.62 [0.42, 0.91]
Comparison 7. Multifaceted intervention versus no intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 CL cases 1 3631 Risk Ratio (Fixed, 95% CI) 0.45 [0.13, 1.50]
2 Seroconversion 2 2436 Risk Ratio (Fixed, 95% CI) 0.80 [0.57, 1.13]
68Vector and reservoir control for preventing leishmaniasis (Review)
Copyright © 2015 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Comparison 8. IRS versus ITNs
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 CL cases 1 Risk Ratio (Random, 95% CI) Subtotals only
1.1 8 months after
intervention
1 1672 Risk Ratio (Random, 95% CI) 1.52 [0.44, 5.32]
1.2 10 months after
intervention
1 1677 Risk Ratio (Random, 95% CI) 1.17 [0.53, 2.60]
1.3 15 months after
intervention
1 1655 Risk Ratio (Random, 95% CI) 1.90 [0.98, 3.69]
Comparison 9. IRS versus ITS
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 CL cases 1 Risk Ratio (Random, 95% CI) Subtotals only
1.1 8 months after
intervention
1 Risk Ratio (Random, 95% CI) 1.05 [0.29, 3.84]
1.2 10 months after
intervention
1 Risk Ratio (Random, 95% CI) 1.17 [0.50, 2.71]
1.3 15 months after
intervention
1 Risk Ratio (Random, 95% CI) 1.83 [0.92, 3.64]
Comparison 10. ITNs versus ITS
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 CL cases 1 Risk Ratio (Fixed, 95% CI) Subtotals only
1.1 8 months after
intervention
1 Risk Ratio (Fixed, 95% CI) 0.69 [0.26, 1.81]
1.2 10 months after
intervention
1 Risk Ratio (Fixed, 95% CI) 1.00 [0.42, 2.34]
1.3 15 months after
intervention
1 Risk Ratio (Fixed, 95% CI) 0.96 [0.45, 2.08]
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Comparison 11. Reservoir control versus IRS
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Seroconversions 1 Risk Ratio (Fixed, 95% CI) 0.56 [0.30, 1.02]
1.1 IRS of houses and animal
pens versus IRS of houses
1 Risk Ratio (Fixed, 95% CI) 0.69 [0.27, 1.76]
1.2 IRS of houses and culling
infected dogs versus IRS of
houses
1 Risk Ratio (Fixed, 95% CI) 0.20 [0.05, 0.85]
1.3 IRS of houses and animal
pens and culling infected dogs
versus IRS of houses
1 Risk Ratio (Fixed, 95% CI) 0.69 [0.27, 1.76]
Analysis 1.1. Comparison 1 IRS versus no intervention, Outcome 1 CL cases.
Review: Vector and reservoir control for preventing leishmaniasis
Comparison: 1 IRS versus no intervention
Outcome: 1 CL cases
Study or subgroup IRS No intervention log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 8 months after intervention
Reyburn 2000 AFG (1) 1083 1860 -0.75192678 (0.37655113) 100.0 % 0.47 [ 0.23, 0.99 ]
Subtotal (95% CI) 1083 1860 100.0 % 0.47 [ 0.23, 0.99 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.00 (P = 0.046)
2 10 months after intervention
Reyburn 2000 AFG 1119 1835 -0.86351443 (0.31428955) 100.0 % 0.42 [ 0.23, 0.78 ]
Subtotal (95% CI) 1119 1835 100.0 % 0.42 [ 0.23, 0.78 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.75 (P = 0.0060)
3 15 months after intervention
Reyburn 2000 AFG 1133 1759 -0.49839315 (0.23734051) 100.0 % 0.61 [ 0.38, 0.97 ]
Subtotal (95% CI) 1133 1759 100.0 % 0.61 [ 0.38, 0.97 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.10 (P = 0.036)
Test for subgroup differences: Chi2 = 0.94, df = 2 (P = 0.62), I2 =0.0%
0.1 0.2 0.5 1 2 5 10
Favours IRS Favours No intervention
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(1) Reyburn 2000 AFG: 26 houses in Urban Kabul were randomized to one of four interventions or control. The insecticide was lambdacyhalothrin (30 mg/m2).
Analysis 1.2. Comparison 1 IRS versus no intervention, Outcome 2 Seroconversion (Montenegro Skin Test).
Review: Vector and reservoir control for preventing leishmaniasis
Comparison: 1 IRS versus no intervention
Outcome: 2 Seroconversion (Montenegro Skin Test)
Study or subgroup IRS No Intervention log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 18 months after intervention
Werneck 2014 BRA (1) 140 -0.15082289 (0.15572844) 155 100.0 % 0.86 [ 0.63, 1.17 ]
Total (95% CI) 140 155 100.0 % 0.86 [ 0.63, 1.17 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.97 (P = 0.33)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours IRS Favours Control
(1) Werneck 2014 BRA: This trial was conducted in an area endemic for VL
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Analysis 2.1. Comparison 2 ITNs versus no intervention, Outcome 1 CL cases.
Review: Vector and reservoir control for preventing leishmaniasis
Comparison: 2 ITNs versus no intervention
Outcome: 1 CL cases
Study or subgroup ITNs No Intervention log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 8 months after intervention
Reyburn 2000 AFG 1282 1860 -1.16177523 (0.38037097) 100.0 % 0.31 [ 0.15, 0.66 ]
Subtotal (95% CI) 1282 1860 100.0 % 0.31 [ 0.15, 0.66 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.05 (P = 0.0023)
2 10 months after intervention
Reyburn 2000 AFG 1257 1835 -1.03696535 (0.30080974) 100.0 % 0.35 [ 0.20, 0.64 ]
Subtotal (95% CI) 1257 1835 100.0 % 0.35 [ 0.20, 0.64 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.45 (P = 0.00057)
3 > 12 months after intervention
Emami 2009 IRN (1) 3810 3815 -4.06771528 (2.27446492) 1.5 % 0.02 [ 0.00, 1.48 ]
Reyburn 2000 AFG (2) 1195 1759 -1.13945702 (0.28437076) 98.5 % 0.32 [ 0.18, 0.56 ]
Subtotal (95% CI) 5005 5574 100.0 % 0.31 [ 0.18, 0.53 ]
Heterogeneity: Chi2 = 1.63, df = 1 (P = 0.20); I2 =39%
Test for overall effect: Z = 4.20 (P = 0.000027)
Test for subgroup differences: Chi2 = 0.14, df = 2 (P = 0.93), I2 =0.0%
0.001 0.01 0.1 1 10 100 1000
Favours ITNs Favours No intervention
(1) Emami 2009 IRN: adjusted for clustering by using the ICC from Rojas 2006 COL. Follow-up 12 months
(2) Reyburn 2000 AFG: Folow-up 15 month
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Analysis 2.2. Comparison 2 ITNs versus no intervention, Outcome 2 VL cases.
Review: Vector and reservoir control for preventing leishmaniasis
Comparison: 2 ITNs versus no intervention
Outcome: 2 VL cases
Study or subgroup ITNs No Intervention log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Fixed,95% CI IV,Fixed,95% CI
Picado 2010a ASIA 9829 9981 -0.0101 (0.39455) 100.0 % 0.99 [ 0.46, 2.15 ]
Total (95% CI) 9829 9981 100.0 % 0.99 [ 0.46, 2.15 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.03 (P = 0.98)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours ITN Favours No intervention
Analysis 2.3. Comparison 2 ITNs versus no intervention, Outcome 3 Seroconversion.
Review: Vector and reservoir control for preventing leishmaniasis
Comparison: 2 ITNs versus no intervention
Outcome: 3 Seroconversion
Study or subgroup ITNs No Intervention log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Picado 2010a ASIA (1) 9829 9981 -0.10536 (0.3097) 100.0 % 0.90 [ 0.49, 1.65 ]
Total (95% CI) 9829 9981 100.0 % 0.90 [ 0.49, 1.65 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.34 (P = 0.73)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours ITNs Favours No intervention
(1) Picado 2010a ASIA: This trial was conducted in an area endemic for VL
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Analysis 3.1. Comparison 3 ITC versus untreated curtains or no curtains, Outcome 1 CL cases.
Review: Vector and reservoir control for preventing leishmaniasis
Comparison: 3 ITC versus untreated curtains or no curtains
Outcome: 1 CL cases
Study or subgroup ITCurtains Control log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Fixed,95% CI IV,Fixed,95% CI
Kroeger 2002 VEN (1) 1351 1587 -5.48797386 (2.43790561) 100.0 % 0.00 [ 0.00, 0.49 ]
Total (95% CI) 1351 1587 100.0 % 0.00 [ 0.00, 0.49 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.25 (P = 0.024)
Test for subgroup differences: Not applicable
0.001 0.01 0.1 1 10 100 1000
Favours ITC Favours Control
(1) Kroeger 2002 VEN: Adjusted for clustering using the ICC from Rojas 2006 COL. Follow-up 12 months.
Analysis 4.1. Comparison 4 ITS versus no intervention, Outcome 1 CL cases.
Review: Vector and reservoir control for preventing leishmaniasis
Comparison: 4 ITS versus no intervention
Outcome: 1 CL cases
Study or subgroup ITS No intervention log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
1 8 months after intervention
Reyburn 2000 AFG 1058 1860 -0.8026812 (0.30751501) 100.0 % 0.45 [ 0.25, 0.82 ]
Subtotal (95% CI) 1058 1860 100.0 % 0.45 [ 0.25, 0.82 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.61 (P = 0.0090)
2 10 months after intervention
Reyburn 2000 AFG 1012 1835 -1.014322 (0.31837627) 100.0 % 0.36 [ 0.19, 0.68 ]
Subtotal (95% CI) 1012 1835 100.0 % 0.36 [ 0.19, 0.68 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.19 (P = 0.0014)
3 15 months after intervention
0.1 0.2 0.5 1 2 5 10
Favours ITS Favours No intervention
(Continued . . . )
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(. . . Continued)
Study or subgroup ITS No intervention log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
Reyburn 2000 AFG 1025 1759 -1.09136397 (0.27339305) 100.0 % 0.34 [ 0.20, 0.57 ]
Subtotal (95% CI) 1025 1759 100.0 % 0.34 [ 0.20, 0.57 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.99 (P = 0.000066)
Test for subgroup differences: Chi2 = 0.51, df = 2 (P = 0.77), I2 =0.0%
0.1 0.2 0.5 1 2 5 10
Favours ITS Favours No intervention
Analysis 5.1. Comparison 5 Insecticide treated uniforms versus no intervention, Outcome 1 CL cases.
Review: Vector and reservoir control for preventing leishmaniasis
Comparison: 5 Insecticide treated uniforms versus no intervention
Outcome: 1 CL cases
Study or subgroup IT Uniforms No intervention Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Asilian 2003a IRN 6/134 9/138 51.1 % 0.69 [ 0.25, 1.88 ]
Soto 1995 COL 4/143 18/143 48.9 % 0.22 [ 0.08, 0.64 ]
Total (95% CI) 277 281 100.0 % 0.40 [ 0.13, 1.20 ]
Total events: 10 (IT Uniforms), 27 (No intervention)
Heterogeneity: Tau2 = 0.37; Chi2 = 2.33, df = 1 (P = 0.13); I2 =57%
Test for overall effect: Z = 1.63 (P = 0.10)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours ITUniforms Favours No intervention
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Analysis 6.1. Comparison 6 Reservoir control versus no intervention, Outcome 1 Serconversion
(Montenegro Skin Test).
Review: Vector and reservoir control for preventing leishmaniasis
Comparison: 6 Reservoir control versus no intervention
Outcome: 1 Serconversion (Montenegro Skin Test)
Study or subgroup Reservoir control No intervention log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 18 months after intervention
Werneck 2014 BRA (1) 221 155 -0.4780358 (0.19724232) 100.0 % 0.62 [ 0.42, 0.91 ]
Subtotal (95% CI) 221 155 100.0 % 0.62 [ 0.42, 0.91 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.42 (P = 0.015)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Reservoir control Favours No Intervention
(1) Werneck 2014 BRA: This trial was conducted in an area endemic for VL
Analysis 7.1. Comparison 7 Multifaceted intervention versus no intervention, Outcome 1 CL cases.
Review: Vector and reservoir control for preventing leishmaniasis
Comparison: 7 Multifaceted intervention versus no intervention
Outcome: 1 CL cases
Study or subgroup
Multifaceted
intervention No intervention log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Fixed,95% CI IV,Fixed,95% CI
Rojas 2006 COL 1791 1840 -0.80591767 (0.61698304) 100.0 % 0.45 [ 0.13, 1.50 ]
Total (95% CI) 1791 1840 100.0 % 0.45 [ 0.13, 1.50 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.31 (P = 0.19)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours Multifaceted intervention Favours No intervention
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Analysis 7.2. Comparison 7 Multifaceted intervention versus no intervention, Outcome 2 Seroconversion.
Review: Vector and reservoir control for preventing leishmaniasis
Comparison: 7 Multifaceted intervention versus no intervention
Outcome: 2 Seroconversion
Study or subgroup
Multifaceted
intervention No intervention log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Fixed,95% CI IV,Fixed,95% CI
Rojas 2006 COL (1) 1066 1034 -0.00578594 (0.34299355) 25.1 % 0.99 [ 0.51, 1.95 ]
Werneck 2014 BRA (2) 181 -0.28768207 (0.19839402) 155 74.9 % 0.75 [ 0.51, 1.11 ]
Total (95% CI) 1247 1189 100.0 % 0.80 [ 0.57, 1.13 ]
Heterogeneity: Chi2 = 0.51, df = 1 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 1.26 (P = 0.21)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Multifaceted int. Favours no intervention
(1) Rojas 2006 COL: This trial was conducted in an area endemic for CL
(2) Werneck 2014 BRA: This trial was conducted in an area endemic for VL
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Analysis 8.1. Comparison 8 IRS versus ITNs, Outcome 1 CL cases.
Review: Vector and reservoir control for preventing leishmaniasis
Comparison: 8 IRS versus ITNs
Outcome: 1 CL cases
Study or subgroup IRS ITN log [Risk Ratio] Risk Ratio Weight Risk Ratio
N N (SE) IV,Random,95% CI IV,Random,95% CI
1 8 months after intervention
Reyburn 2000 AFG (1) 763 909 0.42 (0.6385) 100.0 % 1.52 [ 0.44, 5.32 ]
Subtotal (95% CI) 763 909 100.0 % 1.52 [ 0.44, 5.32 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.66 (P = 0.51)
2 10 months after intervention
Reyburn 2000 AFG 798 879 0.1571 (0.4079) 100.0 % 1.17 [ 0.53, 2.60 ]
Subtotal (95% CI) 798 879 100.0 % 1.17 [ 0.53, 2.60 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.39 (P = 0.70)
3 15 months after intervention
Reyburn 2000 AFG 813 842 0.6441 (0.3381) 100.0 % 1.90 [ 0.98, 3.69 ]
Subtotal (95% CI) 813 842 100.0 % 1.90 [ 0.98, 3.69 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.91 (P = 0.057)
Test for subgroup differences: Chi2 = 0.85, df = 2 (P = 0.65), I2 =0.0%
0.1 0.2 0.5 1 2 5 10
Favours IRS Favours ITN
(1) Within-trial estimation of ICC and DE used to adjust the standard errors in this comparison. A DE of 1.42 was calculated from the adjusted analysis and applied to
the unadjusted analysis by multiplying the SE by the square root of the DE
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Analysis 9.1. Comparison 9 IRS versus ITS, Outcome 1 CL cases.
Review: Vector and reservoir control for preventing leishmaniasis
Comparison: 9 IRS versus ITS
Outcome: 1 CL cases
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
1 8 months after intervention
Reyburn 2000 AFG (1) 0.0525 (0.66) 100.0 % 1.05 [ 0.29, 3.84 ]
Subtotal (95% CI) 100.0 % 1.05 [ 0.29, 3.84 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.08 (P = 0.94)
2 10 months after intervention
Reyburn 2000 AFG 0.1531 (0.4298) 100.0 % 1.17 [ 0.50, 2.71 ]
Subtotal (95% CI) 100.0 % 1.17 [ 0.50, 2.71 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.36 (P = 0.72)
3 15 months after intervention
Reyburn 2000 AFG 0.6058 (0.35) 100.0 % 1.83 [ 0.92, 3.64 ]
Subtotal (95% CI) 100.0 % 1.83 [ 0.92, 3.64 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.73 (P = 0.083)
0.1 0.2 0.5 1 2 5 10
Favours IRS Favours ITChaddar
(1) adjusted for clustering same way as comparison 2
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Analysis 10.1. Comparison 10 ITNs versus ITS, Outcome 1 CL cases.
Review: Vector and reservoir control for preventing leishmaniasis
Comparison: 10 ITNs versus ITS
Outcome: 1 CL cases
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 8 months after intervention
Reyburn 2000 AFG (1) -0.3701 (0.4925) 100.0 % 0.69 [ 0.26, 1.81 ]
Subtotal (95% CI) 100.0 % 0.69 [ 0.26, 1.81 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.75 (P = 0.45)
2 10 months after intervention
Reyburn 2000 AFG -0.0041 (0.435) 100.0 % 1.00 [ 0.42, 2.34 ]
Subtotal (95% CI) 100.0 % 1.00 [ 0.42, 2.34 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.01 (P = 0.99)
3 15 months after intervention
Reyburn 2000 AFG -0.0383 (0.3925) 100.0 % 0.96 [ 0.45, 2.08 ]
Subtotal (95% CI) 100.0 % 0.96 [ 0.45, 2.08 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.10 (P = 0.92)
Test for subgroup differences: Chi2 = 0.37, df = 2 (P = 0.83), I2 =0.0%
0.1 0.2 0.5 1 2 5 10
Favours ITN Favours ITClothes
(1) adjusted for clustering as in comparison 2 above
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Analysis 11.1. Comparison 11 Reservoir control versus IRS, Outcome 1 Seroconversions.
Review: Vector and reservoir control for preventing leishmaniasis
Comparison: 11 Reservoir control versus IRS
Outcome: 1 Seroconversions
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 IRS of houses and animal pens versus IRS of houses
Costa 2007 BRA -0.3711 (0.4787) 41.3 % 0.69 [ 0.27, 1.76 ]
Subtotal (95% CI) 41.3 % 0.69 [ 0.27, 1.76 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.78 (P = 0.44)
2 IRS of houses and culling infected dogs versus IRS of houses
Costa 2007 BRA -1.61 (0.7396) 17.3 % 0.20 [ 0.05, 0.85 ]
Subtotal (95% CI) 17.3 % 0.20 [ 0.05, 0.85 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.18 (P = 0.029)
3 IRS of houses and animal pens and culling infected dogs versus IRS of houses
Costa 2007 BRA -0.37106 (0.4782) 41.4 % 0.69 [ 0.27, 1.76 ]
Subtotal (95% CI) 41.4 % 0.69 [ 0.27, 1.76 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.78 (P = 0.44)
Total (95% CI) 100.0 % 0.56 [ 0.30, 1.02 ]
Heterogeneity: Chi2 = 2.32, df = 2 (P = 0.31); I2 =14%
Test for overall effect: Z = 1.90 (P = 0.057)
Test for subgroup differences: Chi2 = 2.32, df = 2 (P = 0.31), I2 =14%
0.01 0.1 1 10 100
Favours IRS houses/pens Favours IRS houses
A D D I T I O N A L T A B L E S
Table 1. Association between the Leishmania species, its animal reservoir and the sandfly species involved in the leishmaniasis
transmission
CL
Epidemiological
form
Leishmania species Sandfly species Reservoir Clinical form Other clinical
forms
Old World
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Table 1. Association between the Leishmania species, its animal reservoir and the sandfly species involved in the leishmaniasis
transmission (Continued)
Anthroponotic L. tropica P. sergenti Human Urban endemic CL Mucocutaneous, re-
cidivans (chronic)
Zoonotic L. major P. papatasi,P. du-
boscqi
Rodents Rural epidemic CL Mucocutaneous
L. aethiopica P. longipes, P. pedifer Hyraxes CL Diffuse
L. infantum P. perniciosus, P. ari-
asi, P. perfiliewi, P.
longiductus, P. chi-
nensis
Dogs Mucocutaneous
New World
Zoonotic L. mexicana Lu. olmeca Rodents CL Disseminated
L. amazonensis Lu. flaviscutellata Canids, monkeys,
rodents, marsupials
Diffuse,
disseminated
L. braziliensis Lu. intermedia, Lu.
gomezi,Lu.
wellcomei, Lu. whit-
mani,
Lu. carrerai, Lu. yu-
cumensis, Lu. llanos-
martinsi, Lu. spini-
crassa,Lu. ovallesi
Eden-
tates, opossums, ro-
dents and dogs
Mucocutaneous,
disseminated
L. panamensis Lu. rapidoi, Lu.
gomezi, Lu. ylephile-
tor, Lu. panamensis
Sloths, marsupials,
rodents
L. guyanensis Lu. umbratilis, Lu.
whitmani, Lu. an-
duzei, Lu. longiflo-
cosa
Sloths, edentates,
marsupials
Mucocutaneous,
disseminated
Anthroponotic L. peruviana Lu. ayacuchensis, Lu.
peruensis, Lu. verru-
carum
Humans, dogs? Mucocutaneous
(rare)
VL
Epidemiological
form
Leishmania species Sandfly species Reservoir Clinical form Possible outcome
Old World
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Table 1. Association between the Leishmania species, its animal reservoir and the sandfly species involved in the leishmaniasis
transmission (Continued)
Anthroponotic L. donovani P. argentipes, P. ori-
entalis, P. martini
Human VL PKDL
Zoonotic L. infantum P. perniciosus, P. ari-
asi, P.
perfiliewi, P. neglec-
tus, P. longiductus, P.
chinensis and others
Dogs CL
New World
Zoonotic L. infantum
(= L. chagasi)
Lu. longipalpis,Lu.
evansi
Dogs, marsupials VL PKDL (extremely
rare)
Based on WHO 2010.
Abbreviations: CL: cutaneous leishmaniasis; VL: visceral leishmaniasis; PKDL: post kala-azar dermal leishmaniasis.
Table 2. Analysis of cluster-RCTs reporting clinical outcomes
Trial ID Unit Mean cluster
population
Number of clus-
ters
Cluster adjust-
ment by trial
authors
Approxi-
mate ICC calcu-
lated by review
authors1
Cluster adjust-
ment by review
authors2
Costa 2007
BRA
Geographical
area
11 34 “We spec-
ify a model that
explicitly consid-
ered the effect
of aggregation of
the individual in
clusters (cluster
effect) and used
methods
of robust estima-
tion of variance.
Data analysiswas
performed using
STATA software.
”
Unable to calcu-
late because the
raw data were
not presented.
None necessary.
Emami 2009
IRN
Urban sectors 635 12 None
(analysed at the
individual level).
- SE
adjusted for clus-
tering using the
ICC from Rojas
2006 COL.
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Table 2. Analysis of cluster-RCTs reporting clinical outcomes (Continued)
Kroeger 2002
VEN
City sectors 210 14 ’We com-
pared data using
a paired
t test, weighting
the data accord-
ing to the sec-
tor size. We also
used Wilcoxon’s
matched
pairs test because
the small num-
ber of pairs made
it difficult to as-
sess whether the
underly-
ing distribution
of the differences
was normal’
Unable to calcu-
late as
authors only pre-
sented mean dif-
ference adjusted
for clustering
RR was calcu-
lated from raw
data and the SE
adjusted for clus-
tering using the
ICC from Rojas
2006 COL.
Picado 2010a
ASIA
Hamlets 761 26 “Adjusted analy-
ses were carried
out in two stages.
..a standard indi-
vidual level logis-
tic
regression model
to calculate ex-
pected number
of events for each
cluster ignoring
the intervention.
..The ad-
justed interven-
tion effect was
calculated with
these residuals in
a paired t test”
0.0010 None necessary.
Reyburn 2000
AFG
Household 5 957 “Because the in-
ter-
ventions were al-
located at house-
hold level, the
data were anal-
ysed by a random
effects logistic re-
gres-
sionmodel to ad-
0.0321 Converted from
OR to RR using
the formula:
RR = OR/(1-
ACRx(1-OR)).
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Table 2. Analysis of cluster-RCTs reporting clinical outcomes (Continued)
just for the pos-
sibility that indi-
viduals within a
household might
be more similar
with respect to
the inter-
vention outcome
than individuals
from other
households”
Rojas 2006
COL
Village 182 20 “Once the final
model was de-
fined, the gener-
alized estimating
equations
method was used
to estimate the
parameters while
taking into ac-
count the cor-
relation of ob-
servationswithin
villages”
0.0034 None necessary.
Werneck 2014
BRA
City blocks con-
taining 60
households
70 40 “using Pois-
son population-
average models
from generalized
estimating equa-
tions with robust
variance, an ex-
changeable cor-
relation model,
and designating
each block as the
clustering level”
- None necessary.
Abbreviations: BRA = Brazil; IRN = Iran; VEN = Venezuela; AFG = Afghanistan; COL= Colombia; ICC = intra-cluster correlation
co-efficient; SE = standard error; RR = risk ratio; OR = odds ratio.
1We calculated the ICC by comparing the cluster-adjusted SE with the unadjusted SE to calculate the design effect (DE) and then
using the formula: DE = 1+(M-1)*ICC where M=mean cluster size.
2We chose the ICC value by looking for the trial with the most similar size of clusters and number of clusters.
85Vector and reservoir control for preventing leishmaniasis (Review)
Copyright © 2015 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Table 3. Vector density: IRS versus no intervention
Trial ID Unit of
random-
ization
Insecti-
cide
Main vec-
tor
Measure
(method)
Pre-intervention Post-intervention Ef-
fect mea-
sure (95%
CI) or P
valueIRS Control IRS Control
Chowd-
hury
2011
BGD
Cluster of
50 houses Deltamethrin
(20 mg/
m²)
P.
argentipes
Total sand-
flies
(monthly
collec-
tions from
40 houses
using light
traps).
633
(October
2006)
683
(October
2006)
8 (January
2007)
285
(March
2007)
54 (Jan-
uary 2007)
1219
(March
2007)
RR 0.
38 (0.10 to
1.50) (Jan
2007)
RR 0.
28 (0.19 to
0.42) (Mar
2007)
The bene-
fit with
IRS was no
longer
present at
12 months
Joshi
2009
ASIA
Hamlets or
neigh-
bourhoods
Deltamethrin
- BGD
(20 mg/
m²)
DDT -
IND
(1 g/m²)
Alpha-
cyper-
methrin -
NPL
(0.025 g/
m²)
P.
argentipes
Mean
number
of sandflies
per house
per night
(light
traps)
12.32
(date not
stated)
9.41
(Date not
stated)
6.14
(5 months
post inter-
vention)
12.15
(5 months
post inter-
vention)
Pre-inter-
ventionP=
0.184
Post-inter-
ventionP=
0.035
Kelly
1997 BRA
Chicken
sheds
Lambda-
cy-
halothrin
(20 mg/
m²)
Lu.
longipalpis
Geometric
mean
sandflies
(light
traps)
1132.3*
(October
1993)
404.6*
(October
1993)
Not
reported
Not
reported
Pre-inter-
ventionP<
0.001
The trial
authors
state “the
abundance
of Lu.
longipalpis
in sprayed
sheds fell
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Table 3. Vector density: IRS versus no intervention (Continued)
to approxi-
mately
10%
of that ex-
pected,
and re-
mained so
up to week
29”
Felician-
geli
2003 VEN
House Lambda-
cy-
halothrin
(25 mg/
m²)
Lu. ovallesi Total sand-
flies over
79 days
post-inter-
vention
(daily
catches us-
ing light
traps)
Not
reported
Not
reported
2517 2472 The trial
authors
state “The
estimated
catches of
males, fe-
males, and
fed females
were sig-
nificantly
lower
in sprayed
houses im-
mediately
after spray-
ing”.How-
ever, over
time the
density in
the control
group also
decreased -
prob-
ably due to
seasonality
Pro-
portion of
blood fed
females
Not
reported
Not
reported
0.8% 5.8%
Abbreviations: VEN = Venezuela; BRA = Brazil; BGD = Bangladesh; IRS = indoor residual spraying; RR = risk ratio).
Table 4. Incidence of new CL cases by intervention and age group in a cluster-RCT from Afghanistan
Age group (years) IRS ITNs Insecticide treated chaddar Control (no intervention)
New cases (%) New cases (%) New cases (%) New cases (%)
0 to 4 3 (1.9%) 1 (0.6%) 1 (0.8%) 8 (3.7%)
5 to 9 11 (7.9%) 3 (2%) 4 (3.5%) 12 (5.2%)
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Table 4. Incidence of new CL cases by intervention and age group in a cluster-RCT from Afghanistan (Continued)
10 to 19 8 (4.5%) 5 (2.5%) 4 (2.1%) 31 (9.1%)
≥ 20 14 (4.2%) 11 (3.3%) 9 (3.0%) 41 (8.4%)
Total 36 (4.4%) 20 (2.4%) 18 (2.5%) 92 (7.2%)
Adapted from Reyburn 2000 AFG. Age distribution of new CL cases among the non-immune participants at the end of the trial.
Acording to trial authors, the age distribution of new cases was not significantly different between the intervention groups (P =
0.48).
Table 5. Vector density: ITNs versus no intervention
Trial ID Unit of
random-
ization
Interven-
tion
Main vec-
tor
Measure
(method)
Pre-intervention Post-intervention Ef-
fect mea-
sure (95%
CI) or P
valueITNs Control ITNs Control
Chowd-
hury
2011
BGD
Cluster of
50 houses
Per-
maNet®
2.0
(deltamethrin
55mg/m²)
distributed
to all
house-
holds in
November
2006
P.
argentipes
Total sand-
flies
(monthly
collec-
tions from
40 houses
using light
traps).
724
(October
2006)
683
(October
2006)
18 (Jan-
uary 2007)
361
(March
2007)
54 (Jan-
uary 2007)
1219
(March
2007)
RR 0.
73 (0.23 to
2.25) (Jan
2007)
RR 0.
31 (0.21 to
0.46) (Mar
2007)
The bene-
fit
with ITNs
was still
present at
12 months
Emami
2009 IRN
City sector
(ap-
prox. 3000
houses)
Ol-
yset® (per-
methrin
2%) dis-
tributed to
all house-
holds
in August
2004
P. sergenti Total sand-
flies
(monthly
collec-
tions dur-
ing trans-
mis-
sion season
using light
traps
and sticky
traps)
Not
reported
Not
reported
Not
reported
Not
reported
The au-
thors state:
’There
were statis-
tically sig-
nificant
differences
in the
monthly
catches of
P.
sergenti be-
tween con-
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Table 5. Vector density: ITNs versus no intervention (Continued)
trol and in-
tervention
sectors in
both cities
(P < 0.05)’
Joshi
2009
ASIA
Hamlets or
neigh-
nourhoods
Per-
maNet®
(deltamethrin
55mg/m²)
distributed
to all
house-
holds (date
not stated)
P.
argentipes
Mean
number of
sandflies
per per
house
(light
traps) per
night at
all sites
pooled
in Nepal,
Bangladesh
and India
9.92
(date not
stated)
9.41
(date not
stated)
8.32
(5 months
post inter-
vention)
12.15
(5 months
post inter-
vention)
Pre-inter-
ventionP=
0.798
Post-inter-
ventionP=
0.16
(The trial
authors
state the
effect was
signifi-
cant in
India and
Bangladesh
but not
Nepal)
Abbreviations: IRN = Iran; BGD = Bangladesh; ITNs = insecticide treated nets; RR = risk ratio).
Table 6. Vector density: ITNs versus untreated nets
Trial ID Unit of ran-
domization
Intervention Main vector Measure
(method)
Pre-
intervention
Post-
intervention
Ef-
fect measure
(95% CI) or
P value
Dinesh 2008
IND
Two houses 1. Olyset®
polyethylene
net,
impregnated
with
permethrin
(2%).
2. PermaNet®
2.0
impregnated
with
deltamethrin
(55mg/m²).
3. Control:
Untreated
P. argentipes
andSergentomyia
spp.
Geomet-
ric mean sand-
fly counts per
group
(CDC light
traps)
Reported
graphically
Reported
graphically
The trial au-
thors
state a statis-
tically signifi-
cant reduction
in male P. ar-
gentipides
in areas with
ITNs com-
pared to un-
treated nets,
but no differ-
ence in female
P. argentipides
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Table 6. Vector density: ITNs versus untreated nets (Continued)
locally made
net.
or other vec-
tors.
Abbreviations: IND = India; CDC = Centers for Disease Control and Prevention.
Table 7. Vector density: ITCs versus untreated curtains or no curtains
Trial ID Unit of
random-
ization
Interven-
tion
Main vec-
tor
Measure
(method)
Pre-intervention Post-intervention Ef-
fect mea-
sure (95%
CI) or P
valueITNs Control ITNs Control
Kroeger
2002 VEN
City
sectors
Polyester
curtains
impreg-
nated with
lambdacy-
halothrin
(12.5 mg/
m²) at 0
and
6 months.
The mesh
size of cur-
tains was 0.
05 mm
L. youngi
and L.
ovallesi
Mean
number
of sandflies
per house
(light trap
in
main room
of house
for 150
nights).
15
(January to
June 2000)
16
(January to
June 2000)
2
(August
to October
2000)
17
(August
to October
2000)
Pre-inter-
ventionP=
0.706
Post-inter-
ventionP<
0.001
Abbreviations: VEN = Venezuela; ITNs = insecticide treated nets; ITCs = insecticide treated curtains.
Table 8. Vector density: ITS versus no intervention
Trial ID Unit of
random-
ization
Interven-
tion
Main vec-
tor
Measure
(method)
Pre-intervention Post-intervention Ef-
fect mea-
sure (95%
CI) or P
valueITS Control ITS Control
Kelly
1997 BRA
Chicken
sheds
Sheets im-
pregnated
with lamb-
dacy-
halothrin
(20
mg/m²) in-
stalled 1
meter from
Lu. longi-
palpis
Geometric
mean
sandflies
(light
traps)
622.3
(October
1993)
404.6
(October
1993)
Not
reported
Not
reported
The trial
au-
thors state
“the abun-
dance in
sheds was
approxi-
mately
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Table 8. Vector density: ITS versus no intervention (Continued)
the
chicken
shed
50%below
that
expected
on the first
day falling
to
about 80%
at week 12
- the only
time the
difference
was statis-
tically sig-
nificant”
Abbreviations: BRA = Brazil: ITS = insecticide treated sheet.
Table 9. Vector density: EVM versus no intervention
Trial ID Unit of
random-
ization
Interven-
tion
Main vec-
tor
Measure
(method)
Pre-intervention Post-intervention Ef-
fect mea-
sur (95%
CI)
or
P valueEVM Control EVM Control
Chowd-
hury
2011
BGD
Cluster of
50 houses
Com-
munity
mobilizers
conducted
weekly
home
visits and
educated
household
members.
The major
activity
was filling
cracks and
crevices in
the walls
and floors
of human
dwellings,
detached
kitchens,
cattle
sheds,
and other
structures
such as
cattle
troughs
with mud
plaster
P.
argentipes
Total sand-
flies
(monthly
collec-
tions from
40 houses
using light
traps).
662
(October
2006)
683
(October
2006)
43
(January
2007)
954
(March
2007)
54
(January
2007)
1219
(March
2007)
RR 0.
91 (0.31 to
2.63)
(January
2007)
RR 0.
82 (0.57 to
1.17)
(March
2007)
The differ-
ence was
not statis-
tically sig-
nificant
at any time
point up to
12 months
Joshi
2009
ASIA
Hamlets or
neigh-
nourhoods
Commu-
nity mobi-
lizers pro-
moted fill-
ing of
P.
argentipes
Mean
number of
sandflies
per per
13.21
(date not
stated)
9.41
(date not
stated)
10.39
(5 months
post inter-
vention)
12.15
(5 months
post inter-
vention)
Pre-inter-
ventionP=
0.108
Post-inter-
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Table 9. Vector density: EVM versus no intervention (Continued)
cracks and
crevices in
houses and
cattle sheds
In
Nepal and
India: wall
plastering
with lime/
mud mix-
ture was
promoted
(lime was
pro-
vided free
of charge)
In
Bangladesh:
wall plas-
tering with
mud only
(a token
incentive
was pro-
vided)
house
(light trap)
per night
at all sites
pooled
in Nepal,
Bangladesh
and India
ventionP=
0.503
Abbreviations: BGD = Bangladesh; EVM = environmental modification.
Table 10. Vector density: IRS versus ITNs
Trial ID Inter-
vention 1/
Interven-
tion 2
Main vector Measure
(method)
Pre-intervention Post-interventions P value
IRS ITN IRS ITN
Chowd-
hury
2011 BGD
IRS with 20
mg/per m²
deltamethrin.
versus
ITN Per-
maNet®2.0
distributed
to all house-
holds
in Novem-
ber 2006
P. argentipes Total sand-
flies
(monthly
collections
from 40
houses using
light traps).
633
(October
2006)
724
(October
2006)
644
(October
2007)
189
(October
2007)
Not
reported
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Table 10. Vector density: IRS versus ITNs (Continued)
Joshi 2009
ASIA
IRS
Bangladesh:
20 mg/
m²deltamethrin.
In-
dia: 1 g/m²
5% DDT
Nepal: 0.
025 g/
m² alpha-
cyperme-
thrin
versus
ITN
PermaNet®
distributed
to all house-
holds (date
not stated),
P. argentipes Mean num-
ber of sand-
flies per per
house (light
trap) per
night at all
sites pooled
in Nepal,
Bangladesh
and India
12.32
(date not
stated)
9.92
(date not
stated)
6.14
(5 months
post inter-
vention)
8.32
(5 months
post inter-
vention)
Not
reported
Abbreviations: BGD = Bangladesh; IRS = indoor residual spraying; ITNs = insecticide treated nets.
Table 11. Vector density: IRS versus ITS
Trial ID Inter-
vention 1/
Interven-
tion 2
Main vector Measure
(method)
Pre-intervention Post-intervention P value
IRS ITS IRS ITS
Kelly 1997
BRA
IRS with 20
mg/
m² of 10%
lambdacy-
halothrin.
versus
ITS with 20
mg/m² of
lambdacy-
halothrin in-
stalled c. 1
m from the
roost
Lu.
longipalpis
Ln
Odds Ratio
(IRS:ITS)
In
sheds which
were to be
sprayed. Ge-
ometric
mean abun-
dance of
Lu. longi-
palpis (males
+ females):
1132.3
(1 to 2 pre-
intervention
trapping
rounds were
conducted
from 16 Oc-
tober to 11
In
sheds wich
were to re-
ceive targets
sheets. Geo-
metric mean
abundance
of
Lu. longi-
palpis (males
+ females):
622.3
(1 to 2 pre-
intervention
trapping
rounds were
conducted
from 16 Oc-
0.23
Sheds, time
range not re-
ported
(x2 = 6.12).
90% reduc-
tion in Lu.
longipalpis
abundance
Dining-
huts, not re-
ported
Houses, not
reported
Measured as
Ln Odds ra-
tio (IRS:
ITS)
Fol-
lowing blan-
ket interven-
tion, the
abun-
dance of Lu.
longipalpis
in traps fell
by 45% (not
significant).
Catches
at untreated
dining-huts
< 0.025
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Table 11. Vector density: IRS versus ITS (Continued)
November
1993)
tober to 11
November
1993)
actually in-
creased, pos-
sibly because
the blan-
ket coverage
diverted Lu.
longipalpis
away from
major aggre-
gation sites
at animal
pens.
Abbreviations: BRA = Brazil; IRS = indoor residual spraying; ITS = insecticide treated sheets.
Table 12. Vector density: IRS versus EVM
Trial ID Inter-
vention 1/
Interven-
tion 2
Main vector Measure
(method)
Pre-intervention Post-intervention P value
IRS EVM IRS EVM
Chowd-
hury
2011 BGD
IRS with 20
mg/per m²
deltamethrin.
versus
EVM
Filling
cracks
and crevices
in the walls
and floors of
human
dwellings,
detached
kitchens,
cattle sheds,
and
other struc-
tures. Pro-
motion of
cleaning up
debris from
the environ-
ment
using house-
hold incen-
tives
P. argentipes Total sand-
flies
(monthly
collections
from 40
houses using
light traps).
633
(October
2006)
662
(October
2006)
644
(October
2007)
598
(October
2007)
Not
reported
Joshi 2009
ASIA
IRS
Bangladesh:
20 mg/m²
deltamethrin.
In-
dia: 1 g/m²
5% DDT
Nepal: 0.
025 g/m² al-
pha-cyper-
methrin.
versus
P. argentipes Mean num-
ber of sand-
flies per per
house (light
trap) per
night at all
sites pooled
in Nepal,
Bangladesh
and India
12.32
(date not
stated)
13.21
(date not
stated)
6.14
(5 months
post inter-
vention)
10.39
(5 months
post inter-
vention)
Not
reported
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Table 12. Vector density: IRS versus EVM (Continued)
EVM
Trained
community
mobilizers
met with
each family
to discuss
the typical
resting and
breeding
sites in and
around the
houses and
the appro-
priate ways
to reducing
them. In
Nepal and
India wall
plastering
with lime/
mud mix-
ture was
promoted,
the lime
being pro-
vided free
of charge to
the house-
holds. In
Bangladesh
plastering
was done
with mud
only
Abbreviations: IRS = indoor residual spraying; EVM = environmental modification.
Table 13. Vector density: ITNs versus EVM
Trial ID Inter-
vention 1/
Interven-
tion 2
Main vector Measure
(method)
Pre-intervention Post-intervention P value
ITNs EVM ITNs EVM
Chowd-
hury
2011 BGD
ITNs Per-
maNet®
made of
P. argentipes Total sand-
flies
(monthly
724
(October
2006)
662
(October
2006)
18
(January
2007)
598
(October
2007)
Not
reported
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Table 13. Vector density: ITNs versus EVM (Continued)
polyester
containing
deltamethrin
(55 mg/m²)
versus
EVM
Filling
cracks
and crevices
in the walls
and floors of
human
dwellings,
detached
kitchens,
cattle sheds,
and
other struc-
tures. Pro-
motion of
cleaning up
debris from
the environ-
ment
using house-
hold incen-
tives
collections
from 40
houses using
light traps)
361
(March
2007)
Joshi 2009
ASIA
ITNs Per-
maNet®
made of
polyester
containing
deltamethrin
(55 mg/m²)
versus
EVM
Trained
co munity
mobilizers
met with
each family
to discuss
the typical
resting and
breeding
sites in and
around the
houses and
the appro-
priate ways
to reducing
them. In
Nepal and
India wall
plastering
with lime/
mud mix-
ture was
promoted,
the lime
being pro-
vided free
of charge to
the house-
holds. In
Bangladesh
plastering
was done
with mud
only
P. argentipes Mean num-
ber of
sandflies per
house (light
trap) per
night at all
sites pooled
in Nepal,
Bangladesh
and India
9.92
(date not
stated)
13.21
(date not
stated)
8.32
(5 months
post inter-
vention)
10.39
(5 months
post inter-
vention)
Not
reported
Abbreviations: BGD = Bangladesh; ITNs = insecticide treated nets; EVM = environmental modification.
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A P P E N D I C E S
Appendix 1. CIDG Specialized Register search strategy
Leshman* AND (prophyla* OR prevent*)
Appendix 2. Cochrane Library search strategy
#1 (prevent*)
#2 (phlebotomus)
#3 (insect*)
#4 (repel*)
#5 (permethrin* or permetrin*)
#6 (sand fly* or sand fli* or sand fly* or sand fli*)
#7 (Lutzom*)
#8 (environment*)
#9 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8)
#10 leishmania*
#11 (#9 AND #10)
Appendix 3. MEDLINE (PubMed) search strategy
1. prevent*
2. phlebotomus
3. insect*
4. repel*
5. permethrin* OR permetrin
6. sand fly* OR sand fli* OR sandfly* OR sanfli*
7. Lutzom*
8. environment*
9. 1 OR 2 OR 3 OR 4 OR 5 OR 6 Or 7 OR 8
10. leishmania*
11. 9 AND 10
12. randomised controlled trial OR randomized controlled trial
13. controlled clinical trial
14. randomi*
15. placebo
16. clinical trials as topic
17. randomly
18. trial
19. 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18
20. 11 AND 19
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Appendix 4. EMBASE search strategy
1. PREVENT$
2. PHLEBOTOMUS
3. INSECT$
4. REPEL$
5. PERMETHRIN$ OR PERMETRIN
6. SAND ADJ FLY$ OR SAND ADJ FLI$ OR SANDFLY$ OR SANFLI$
7. LUTZOM$
8. ENVIRONMENT$
9. 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8
10. LEISHMANIA$
11. 9 AND 10
12. FACTORIAL$
13. RANDOMIZED ADJ CONTROLLED ADJ TRIAL
14. CONTROLLED ADJ CLINICAL ADJ TRIAL
15. RANDOMIZED
16. PLACEBO$
17. CLINICAL-TRIAL.DE.
18. RANDOM$
19. CROSSOVER$ OR CROSS ADJ OVER$ OR CROSS?OVER$ OR CROSSOVER?PROCEDURE
20. DOUBL$ ADJ BLIND$ OR SINGL$ ADJ BLIND$ OR DOUBLE?BLIND ADJ PROCEDURE OR SINGLE?BLIND ADJ
PROCEDURE
21. TRIAL
22. 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18 OR 19 OR 20 OR 21
23. 11 AND 22
Appendix 5. LILACS search strategy
((Pt ENSAYO CONTROLADO ALEATORIO OR Pt ENSAYO CLINICO CONTROLADO OR Mh ENSAYOS CONTROLA-
DOS ALEATORIOSORMhDISTRIBUCIÓN ALEATORIAORMhMETODODOBLE CIEGOORMhMETODO SIMPLE-
CIEGO OR Pt ESTUDIO MULTICÉNTRICO) or ((tw ensaio or tw ensayo or tw trial) and (tw azar or tw acaso or tw placebo or
tw control$ or tw aleat$ or tw random$ or (tw duplo and tw cego) or (tw doble and tw ciego) or (tw double and tw blind)) and tw
clinic$)) AND NOT ((Ct ANIMALES OR Mh ANIMALES OR Ct CONEJOS OR Ct RATÓN OR MH Ratas OR MH Primates
ORMH Perros OR MH Conejos ORMH Porcinos) AND NOT (Ct HUMANO AND Ct ANIMALES)) [Palabras] and leishmani$
[Palabras] and (preven$ OR phlebotomus OR insect$ OR repel$ OR (permethrin$ OR permetrin$) OR (sand fly$ OR sand fli$ OR
sandfly$ OR sandfli$ OR mosc$) OR Lutzom$ OR environment$ OR ambient$) [Palabras]
Appendix 6. WHOLIS search strategy
words or phrase “((randomised controlled trial OR controlled clinical trial OR randomised OR placebo OR clinical trials as topic OR
randomly OR trial) NOT (animals NOT humans))” AND words or phrase “leishmania$”
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Appendix 7. Science Direct search strategy
1. prevent*
2. phlebotomus
3. insect*
4. repel*
5. permethrin* OR permetrin
6. sand fly* OR sand fli* OR sandfly* OR sanfli*
7. Lutzom*
8. environment*
9. 1 OR 2 OR 3 OR 4 OR 5 OR 6 Or 7 OR 8
10. LEISHMANIA*
11. 9 AND 10
12. randomised controlled trial OR randomized controlled trial
13. controlled clinical trial
14. randomi*
15. placebo
16. clinical trials as topic
17. randomly
18. trial
19. 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18
20. HUMANS NOT ANIMALS
21. 11 AND 19 AND 20
Appendix 8. RePORTER search strategy
1. leishmania*
2. prevent*
3. 1 AND 2
Appendix 9. Ongoing trials search strategies
metaRegister of Controlled trials
leishmania* AND prevent*
US National Institutes of Health Register
leishmania
Ongoing Skin Trials Register
leishmania
Australian and New Zealand Clinical Trials Registry
leishmania
WHO ICTRP
leishmania* and prevent*
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Appendix 10. MEDLINE (PubMed) adverse effects
(“adverse effects”[Subheading] OR (“adverse”[All Fields] AND “effects”[All Fields]) OR “adverse effects”[All Fields]) AND ((“cyperme-
thrine”[Supplementary Concept] OR “cypermethrine”[All Fields] OR “alphacypermethrin”[All Fields]) OR (“ddt”[MeSH Terms] OR
“ddt”[All Fields]) OR (“permethrin”[MeSH Terms] OR “permethrin”[All Fields]) OR (“deet”[MeSH Terms] OR “deet”[All Fields])
OR noike[All Fields] OR (“decamethrin”[Supplementary Concept] OR “decamethrin”[All Fields] OR “deltamethrin”[All Fields]) OR
(“cyhalothrin”[SupplementaryConcept]OR “cyhalothrin”[All Fields]OR “lambdacyhalothrin”[All Fields])) AND(Review[ptyp] AND
“2005/01/07”[PDat] : “2015/01/04”[PDat] AND “humans”[MeSH Terms])
C O N T R I B U T I O N S O F A U T H O R S
UG was a link with the editorial base and coordinated contributions from review co-authors.
AF and MP searched for trials (including developed a search strategy, obtained papers, contacted authors, investigators or drug
companies).
CE, AF, UG, MP and IV selected trials for inclusion and extracted data from included trials.
MP, UG and DS entered data into RevMan 2014.
TE, DS and UG performed analyses.
AF, UG, MT, CE, DS, JA interpreted the data.
All review authors drafted the final review.
JA and IV, the expert representatives, focused on relevance and applicability of the Cochrane Review.
D E C L A R A T I O N S O F I N T E R E S T
None known (All).
S O U R C E S O F S U P P O R T
Internal sources
• Liverpool School of Tropical Medicine, UK.
External sources
• Office of Control of Neglected Tropical Diseases (WHO/CDS/NTD/IDM), Communicable Disease Cluster, World Health
Organization, Switzerland.
• Agencia Española de Cooperación Internacional para el Desarrollo (AECID), Spain.
• Department for International Development (DFID), United States Minor Outlying Islands.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We changed the primary outcome from “Reduction (%) of cases (incidence) of leishmaniasis” in González 2010 to “cases of leishma-
niasis”.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Disease Vectors; ∗Insecticides; Animal Culling; Clothing; Disease Reservoirs [∗parasitology]; Dog Diseases [prevention & control];
Dogs; Household Articles; Insecticide-Treated Bednets; Leishmaniasis, Cutaneous [∗prevention & control; veterinary]; Leishmaniasis,
Visceral [∗prevention & control; veterinary]; Population Density; Randomized Controlled Trials as Topic
MeSH check words
Animals; Humans
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